THE COMPLETE LIST OF
PLAINTIFFS’ EXHIBITS
referred to in Chapter Forty-Five.

In alphabetical order, and then chronological order
for multiple listings by the same author.

But first,

IN A CATEGORY OF ITS OWN

> Secretary Sullivan, Department of Health and Human Services, “No Cause for Alarm over HIV-negative immune deficiency,” AIDS Weekly, August 3, 1992, pp. 2-5.

A

> Adams, J., AIDS: The HIV Myth, St. Martin’s Press, New York, 1989.
> Afrasiabi, R., et al., “Characterization of a distinct subgroup of high-risk persons with Kaposi’s sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic results,” American Journal of Medicine, 81 (1986), pp. 969-973.
> AIDS-Hemophilia French Study Group, “Immunologic and virologic status of multitransfused patients: role of type and origin of blood products,” Blood, 66 (1985), pp. 896-901.
> Alcabes, P., et al., “Correlates of the Rate of Decline of CD4+ Lymphocytes Among Injection Drug Users Infected with Human Immunodeficiency Virus,” American Journal of Epidemiology, 137 (1993), pp. 989-1000.
> Aledort, L. M. “Blood products and immune changes: impacts without HIV infection,” Seminars in Hematology, 25 (1988), pp. 14-19.
> Alroomi, L., et al., “Maternal narcotic abuse and the newborn,” Archives of Disease in Childhood, 63 (1988), pp. 81-83.
> Altman, L. K., “Researchers believe AIDS Virus is Found,” New York Times, April 24, 1984.
> Altman, L. K., “AIDS Mystery: Why Do Some Infected Men Stay Healthy?,” New York Times, June 30, 1987.
> Altman, L. K., “New Virus Said to Cause a Condition Like AIDS,” New York Times, July 23, 1992.
> Altman, L. K., “Working in public to explain AIDS-like ills,” New York Times, August 18, 1992.
> Altman, L. K., “Group with HIV has no symptoms,” New York Times, October 9, 1992.
> Altman, L. K., “Treatment Guidelines for HIV Amended,” San Francisco Chronicle, June 28, 1993.
> Altman, L. K., “Obstacle-Strewn Road to Rethinking the Numbers of AIDS,” New York Times, 1994.
> Altman, L. K., “Going off the Beaten Path to Track Down Clues About AIDS,” New York Times, December 20, 1994.
> Altman, L. K., “AIDS Cancer Said to Have Viral Source,” New York Times, February 1, 1995.
> Altman, L. K., “Experts to Review AZT Role as the Chief Drug for H.I.V.,” New York Times, September 17, 1995.
> Altman, L. K., “Scientists Display Substantial Gains in AIDS Treatment,” New York Times, July 11, 1996.
> Amaro, H., et al., “Drug use among adolescent mothers: profile of risk,” Pediatrics, 84 (1989), pp. 144-151.
> Anand, R., et al., “Non-natural Variants of Human Immunodeficiency Virus Isolated from AIDS Patients with Neurological Disorders,” Lancet, ii (1987), pp. 234-238.
> Anderson, D. J., et al., “Effects of Disease Stage and Zidovudine Therapy on the Detection of Human Immunodeficiency Virus Type I in Semen,” Journal of the American Medical Association, 267 (1992), pp. 2769-2774.
> Anderson, J., “AIDS in Thailand,” British Medical Journal, 300 (1990), pp. 415-416.
> Anderson, L. F., “Cancer Act anniversary encourages reflections, new visions,” Journal of the National Cancer Institute, 83 (1991), pp. 1795-1796.
> Anderson, R. M. and R. M. May, “Epidemiological Parameters of HIV Transmission,” Nature (London), 333 (1988), pp. 514-519.
> Anderson, R. M. and R. M. May, “Understanding the AIDS Pandemic,” Scientific American, 266 (1992), pp.20-26.
> Anderson, W., Drug Smuggling, U.S. General Accounting Office, Washington, D.C., 1987.
> Annell, A., et al., “HIV-Prevalence and mortality in relation to type of drug abuse among drug addicts in Stockholm 1981-1988,” in Drug Addiction and AIDS, N. Loimer, R. Schmid, and A. Springer (Editors), Springer-Verlag, New York, 1991.
> Anonymous, “The Cause of AIDS?,” Lancet, i (1984), pp. 1053-1054.
> Anonymous, “Why the AIDS Virus is Not Like HTLVs I or II,” New Scientist, February 7, 1985, p. 4.
> Anonymous, “Projections Show Rising Worldwide AIDS Toll,” American Medial News, 40, May 8, 1987.
> Anonymous, “American Boy Died of AIDS 18 Years Ago,” Daily Telegraph (UK), October 26, 1987.
> Anonymous, “Revised Case Definition of AIDS,” British Medical Journal, October 31, 1987, p. 1125.
> Anonymous, “AIDS in Africa,” Lancet, ii (1987), pp. 192-194.
> Anonymous, “Senate approves measures on transit and AIDS,” New York Times, August 6, 1990.
> Anonymous, “Zidovudine for symptomless HIV infection,” Lancet, 335 (1990), pp. 821-822.
> Anonymous, “Dentist-infected AIDS patient dies,” Dallas Morning News, December 9, 1991.
> Anonymous, “AIDS Victim’s Will is a Moving ‘Good-bye’,” San Francisco Chronicle, January 15, 1992.
> Anonymous, “Doubts about zidovudine,” Lancet, 339 (1992), p. 421.
> Anonymous, “Patient Accuses Kaiser,” Oakland Tribune, December 1, 1992.
> Anonymous, “New U.S. AIDS Study Assailed by Activists,” San Francisco Chronicle, February 8, 1993.
> Anonymous, “Study Questions Whether Dentist Spread AIDS,” Orange County Register, February 25, 1993.
> Anonymous, “HIV Seroconversion After Occupational Exposure Despite Early Prophylactic Zidovudine Therapy,” Lancet, 341 (1993), pp. 1077-1078.
> Anonymous, “Zidovudine for Mother, Fetus, and Child: Hope or Poison?,” Lancet, 344 (1994), pp. 207-209.
> Anonymous, “Head of National Cancer Institute to Quit,” San Francisco Chronicle, December 23, 1994.
> Anonymous, “Defending the Indefensible Dr. Gallo,” Chicago Tribune, January 6, 1995.
> Anonymous, “Clever Drug or Is It the Marketing?,” Continuum, 3 (1995), p. 2.
> Anonymous, “Government Congressman Questions Funding for AIDS Research,” AIDS Weekly (electronic version), May 22, 1995.
> Anonymous, Keeping Score: What We Are Getting for Our Federal Drug Control Dollars, Drug Strategies, Washington, D.C., 1995.
> Anonymous, “Zidovudine Use Can Reduce Numbers of HIV Infected Babies Being Born,” AIDS Weekly, October 2, 1995, p. 11.
> Anonymous, “Doctor Afraid To Speak Out on MS,” Continuum, 3 (November/December 1995), p. 3.
> Anonymous, “Drugs Boost,” Continuum, 4 (1996), p. 3.
> Anonymous, The Relationship Between Human Immunodeficiency Virus and the Acquired Immunodeficiency Syndrome, National Institute for Allergy & Infectious Diseases, Maryland, 1996.
> Antonaci, S., et al., “Immunoresponsiveness in hemophilia: Lymphocyte- and Phagocyte-mediated functions,” Diagnostic Clinical Immunology, 5 (1988), pp. 318-325.
> Antonio, G., The AIDS Cover-Up: The Real and Alarming Facts About AIDS, Ignatius Press, California, 1986.
> Aoun, H., “When a house officer gets AIDS,” New England Journal of Medicine, 321 (1989), pp. 693-696.
> Aral, S. O. and K. K. Holmes, “Sexually transmitted disease in the AIDS era,” Scientific American, 264 (1991), pp. 62-69.
> Archer, C. B., et al., “Kaposi’s sarcoma in a homosexual - ten years on,” Clinical and Experimental Dermatology, 14 (1989), pp. 233-236.
> Archibald, C. P., et al., “Evidence for a sexually transmitted cofactor for AIDS-related Kaposi’s sarcoma in a cohort of homosexual men,” Epidemiology, 3 (1992), pp. 203-209.
> Aronson, D. L., “Pneumonia deaths in haemophiliacs,” Lancet, ii (1983), p. 1023.
> Aronson, D. L., “Cause of death in hemophilia patients in the United States from 1968-1979,” American Journal of Hematology, 27 (1988), pp. 7-12.
> Ascher, M. S., et al., “Does Drug Use Cause AIDS,” Nature, 362 (1993), pp. 103-104.
> Ascher, M. S., et al., “AIDS-associated Kaposi's Sarcoma,” Science, 267 (1995), p. 1080.
> Ascher, M. S., et al., “Paradox Remains,” Nature, 375 (1995), p. 196.
> Ashe, A., “More Than Ever, Magical Things to Learn,” Washington Post, October 11, 1992.
> Ashe, A. and A. Rampersad, Days of Grace: A Memoir, Alfred A. Knopf, New York, 1993.
> Associated Press, “Red Cross knew of AIDS blood threat,” San Francisco Chronicle, May 16, 1994.
> Auerbach, D. M., et al., “Cluster of Cases of the Acquired Immune Deficiency Syndrome Patients Linked by Sexual Contact,” American Journal of Medicine, 76 (1984) pp. 487-492.
> Avramis, V. I., et al., “Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM),” AIDS, 3 (1989), pp. 417-422.
> Aylward, E. H., et al., “Cognitive and motor development in infants at risk for Human Immunodeficiency Virus,” American Journal of Diseases of Children, 146 (1992), pp 218-222.

B

> Bacellar, H., et al., “Temporal Trends in the Incidence of HIV-I-related Neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992,” Neurology, 44 (1994), pp. 1892-1900.
> Bagasra, O., et al., “Detection of human immunodeficiency virus type I provirus in mononuclear cells by in situ polymerase chain reaction,” New England Journal of Medicine, 326 (1992), pp. 1385-1391.
> Balter, M., “Montagnier Pursues the Mycoplasm-AIDS Link,” Science, 251 (1991), p. 271.
> Baltimore, D., and M. B. Feinberg, “HIV Revealed: Toward a Natural History of the Infection,” New England Journal of Medicine, December 14, 1989.
> Baltimore, D. and M. B. Feinberg, “Quantification of Human Immunodeficiency Virus in the Blood,” New England Journal of Medicine, 322 (1990), pp. 1468-1469.
> Balzarini, J., et al., “Differential Patterns of Intracellular Metabolism of 2',3'-didehydro- 2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, Two Potent Anti-Human Immunodeficiency Virus Compounds,” Journal of Biological Chemistry, 264 (1989), pp. 6127-6133.
> Bardach, A. L., “The Heretic,” Buzz (January/February 1992), pp. 68-73, 90, 92.
> Barinaga, M., “Confusion on the cutting edge,” Science, 257 (1992), pp. 616-619.
> Barr, S., “The Flawed Case Against Dr. Acer – In Defense of AIDS Dentist,” Miami Herald, March 31, 1994.
> Barr, S., “In Defense of the AIDS Dentist,” Lear’s, April 2, 1994.
> Barr, S., “What If the Dentist Didn’t Do It?,” New York Times, April 16, 1994.
> Bartholomew, C., et al., “Transmission of HTLV-I and HIV Among Homosexual Men in Trinidad,” Journal of the American Medical Association, 257 (1987), pp. 2604-2608.
> Baumann, E., et al., “The Constitution of the Group for the Scientific Reappraisal of the HIV/AIDS Hypothesis,” Science, 267 (1995), p. 945.
> Baumann, E. et al., “AIDS Proposal,” Science, 267 (1995), pp. 945-946.
> Baumann, E. et al., “AIDS Proposal,” AIDS – Forschung, 10 (1995), p. 280.
> Beaglehole, R. V., “Below the Fold,” Lancet, 353 (1999), p. 1719.
> Beardsley, T., “French Virus in the Picture,” Nature (London), 320 (1986), p. 563.
> Becherer, P. R., et al., “Human immunodeficiency virus-I disease progression in hemophiliacs,” American Journal of Hematology, 34 (1990), pp. 204-209.
> Belman, A. L., et al., “Pediatric acquired immunodeficiency syndrome,” American Journal of Diseases of Children, 142 (1988), pp. 29-35.
> Bendit, J. and B. Jasny, “AIDS: The Unanswered Questions,” Science, 260 (1993), pp. 1253-1293.
> Beral, V., et al., “Kaposi’s Sarcoma Among Persons with AIDS: A Sexually Transmitted Infection?,” Lancet, 335 (1990), pp. 123-128.
> Bergeron, L. and J. Sodroski, “Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type I,” Journal of Virology, 66 (1992), pp. 5777-5787.
> Bergman, D. J. and A. D. Langmuir, “Farr’s Law Applied to AIDS Projections,” Journal of the American Medical Association, 263 (1990), pp. 50-57.
> Berkley, S., et al., “Surveillance for AIDS in Uganda,” AIDS, 3 (1989), pp. 79-85.
> Bessen, L., et al., “Severe Polymyositis-like Syndrome Associated with Zidovudine Therapy of AIDS and ARC,” New England Journal of Medicine, March 17, 1988.
> Bethell, T., “Heretic,” The American Spectator, May 1992, pp. 18-19.
> Bethell, T., “The Cure That Failed,” National Review, May 10, 1993.
> Bethell, T., “Do ‘Poppers’ Hold the Secret to One of the Great Mysteries of AIDS?,” Spin, 10 (1994), pp. 87-89, 116.
> Bethell, T., “Kaposi’s, Viruses & Poppers,” Rethinking AIDS, April 1995.
> Bethell, T., “AIDS and poppers,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Bethell, T., The Politically Incorrect Guide to Science, Regnery Publishing, Washington, D.C., 2005.
> Bialy, H., “Commentary: Where is the Virus? And Where is the Press?,” Bio/Technology, February 1988.
> Bialy, H., Oncogenes, Aneuploidy, and Aids: A Scientific Life and Times of Peter H. Duesberg, North Atlantic Books, Berkeley, 2004.
> Bialy, H. and C. Farber, “It’s time to re-evaluate the HIV-AIDS hypothesis,” Rethinking AIDS, 1 (1992), pp. 1-2.
> Biggar, R. J. and the International Registry of Seroconverters, “AIDS incubation in 1891 HIV seroconverters from different exposure groups,” AIDS, 4 (1990), pp. 1059-1066.
> Blanche, S. et al., “A Prospective Study of Infants Born to Women Seropositive for Human Immunodeficiency Virus Type I,” New England Journal of Medicine, 320 (1989), pp. 1643-1648.
> Blanche, S., et al., “Relation of the Course of HIV Infection in Children to the Severity of the Disease in their Mothers At Delivery,” New England Journal of Medicine, 330 (1994), pp. 308-213.
> Blattner, W. A., “HIV Epidemiology: Past, Present, and Future,” FASEB Journal, 5 (1991), pp. 2340-2348.
> Blattner, W. A., et al., “Epidemiology of Human Lymphotropic Retroviruses: An Overview,” Cancer Research, 45 (Supplement) (1985), pp. 4598-4601.
> Blattner, W. A., et al., “HIV Causes AIDS,” Science, 241 (1988), pp. 514-515.
> Bolling, D. R. and B. Voeller, “AIDS and heterosexual anal intercourse,” Journal of the American Medical Association, 258 (1987), p. 474.
> Booth, W. A., “Rebel without a cause for AIDS,” Science, 239 (1988), pp.1484-1488.
> Bowden, F. J., et al., “Antibodies to gp41 and nef in otherwise HIV-negative homosexual men with Kaposi’s sarcoma,” Lancet, 337 (1991), pp. 1313-1314.
> Brandt, A. M., “AIDS in historical perspective: four lessons from the history of sexually transmitted diseases,” American Journal of Public Health, 78 (1988), pp. 367-371.
> Braun, M. M., et al., “Increasing Incidence of Tuberculosis in a Prison Inmate Population, Association with HIV-Infection,” Journal of the American Medical Association, 261 (1989), pp. 393-397.
> Bregman, D. J. and A.D. Langmuir, “Farr's Law Applied to AIDS Projections,” Journal of the American Medical Association, 263 (1990), pp. 50-57.
> Brenner, H., et al., “AIDS among drug users in Europe,” Drug and Alcohol Dependence, 29 (1990), pp. 171-181.
> Breo, D. L. and K. Bergalis, “Meet Kimberly Bergalis – the patient in the ‘dental AIDS case,’” Journal of the American Medical Association, 264 (1990), pp. 2018-2019.
> Brettle, R. P., “Clinical Features of Drug Use and Drug Use Related to HIV,” International Journal of STD & AIDS, 7 (1996), pp. 151-165.
> Brettler, D. B. et al., “Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate,” American Journal of Medicine, 81 (1986), pp. 607-611.
> Brettler, D. B. and P. H. Levine, “Factor concentrates for treatment of hemophilia: which one to choose?,” Blood, 73 (1989), pp. 2067-2073.
> Briggs, L. H., et al., “Severe Systemic Infections Complicating 'Mainline' Heroine Addiction,” Lancet, ii (1967), pp. 1227-1231.
> Brindle, R. J., et al., American Review of Respiratory Diseases, 147 (1993), pp. 958-961.
> Brock, T. D., Robert Koch: A Life in Medicine and Bacteriology, Science Tech Publishers, Wisconsin, 1988.
> Brown, S. M., et al., “Immunological Dysfunction in Heroin Addicts,” Archives of Internal Medicine, 134 (1974), pp. 1001-1006.
> Brudney, K. and L. Dobkin, “Resurgent Tuberculosis in New York City,” American Review of Respiratory Diseases, 144 (1991), pp. 744-749.
> Brun-Vezinet, F., et al., The Lancet i (1984), pp. 1253-1256.
> Bryant, H. U., et al., “Effects of Cocaine and Other Drugs of Abuse on Immune Responses,” in Cocaine: Pharmacology, Physiology and Clinical Strategies, J.M. Lakoski, M.P. Galloway, F.J. White, (Editors), CRC Press, Boca Raton, Florida, 1992.
> Bschor, F., et al., “Monitoring of HIV-Spread in Regional Populations of Injecting Drug Users – the Berlin Experience,” in Drug Addiction and AIDS, N. Loimer, R. Schmid, and A. Springer (Editors), Springer-Verlag, New York, 1991.
> Buchbinder, S. P., et al., “Long-term HIV-I Infection Without Immunologic Progression,” AIDS, 8 (1994), pp. 1123-1128.
> Buehler, J. W., et al., “Impact of the Human Immunodeficiency Virus epidemic on mortality trends in young men, United States,” American Journal of Public Health, 80 (1990), pp. 1080-1086.
> Buimovici-Klein, E., et al., “Virus isolation and immune studies in a cohort of homosexual men,” Journal of Medical Virology, 25 (1988), pp. 371-385.
> Burd, D., "Tap Dancing Toward Two Aspirin A Day," Red Flags, February 11, 2006.
> Bureau of Justice Statistics, Drugs, Crime, and the Justice System, U.S. Department of Justice, Washington, D.C., 1992.
> Burke, D. S., “Human Immunodeficiency Virus Infections in Teenagers: Seroprevalence Among Applicants for the U.S. Military Service,” Journal of the American Medical Association, 263 (1990), pp. 2074-2077.
> Burke, D. S., et al., New England Journal of Medicine, 319 (1988), pp. 961-964.
> Burkett, E., “The Queen of AZT,” Miami Herald, September 23, 1990.
> Burkett, E., “Is HIV guilty?,” Miami Herald, December 23, 1990.
> Burkett, E., The Gravest Show on Earth; America in the age of Aids, Houghton Mifflin Co., 1995.

C

> Callen, M., Surviving AIDS, Harper Perennial, New York, 1990.
> Callen, M., “A Dangerous Talk with Dr. Sonnabend,” QW, September 27, 1992, pp. 42-46, 71-72.
> Callen, M. (Editor), Surviving and Thriving with AIDS: Collected Wisdom, Volume Two, New York.
> Campbell, D., “The Amazing AIDS Scam,” The New Statesman, June 24, 1988.
> Cao, Y., et al., “Virologic and Immunologic Characterization of Long-term Survivors of Human Immunodeficiency Virus Type I Infection,” New England Journal of Medicine, 332 (1995), pp. 201-208.
> Caplan, A., “Just as Simple as AZT,” San Diego Union-Tribune, November 8, 1994.
> Carr, R., et al., “Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population,” Lancet, i (1984), pp. 1431-1343.
> Carroll, “The Weird Way to Win a Nobel Prize,” San Francisco Chronicle, October 21, 1993.
> Casarett, L. J., “Toxicologic Evaluation,” from Toxicology: The Basic Science of Poisons, L.J. Casarett and J. Doull (Editors), McGraw-Hill Professional, 1975.
> Castro, A., et al., “Kaposi’s sarcoma and disseminated tuberculosis in HIV-negative individuals,” Lancet, 339 (1992), p. 868.
> Celum, C. L., et al., Journal of Infectious Diseases, 164 (1991), pp. 656-664.
> Center for Disease Control, “Epidemiological Aspects of the Current Outbreak of Kaposi's Sarcoma and Opportunistic Infections,” New England Journal of Medicine, 306 (1982), pp. 248-252.
> Center for Disease Control, “Pneumocystis carinii pneumonia among persons with hemophilia A,” Morbidity and Mortality Weekly Report 31 (1982), pp. 365-367.
> Center for Disease Control, “Revision of the CDC Surveillance Case Definition for Acquired Immunodeficiency Syndrome,” Journal of the American Medical Association, 258 (1987), pp. 1143-1154.
> Center for Disease Control, AIDS and HIV Infection Among Health-Care Workers, 37, April 1988, pp. 229-239.
> Center for Disease Control, “A Comprehensive HIV Prevention Program,” Public Health Reports, 106 (1991).
> Centers for Disease Control and Prevention, Morbidity and Mortality Weekly Reports, June 1981 to present.
> Centers for Disease Control and Prevention, HIV/AIDS Surveillance Reports, Year-end editions, Mid-year editions (through 2001) and Supplements, 1982 through 2004.
> Chaisson, R. E., et al., “Cocaine use and HIV infection in intravenous drug users in San Francisco,” Journal of the American Medical Association, 261 (1989), pp. 561-565.
> Chang, Y. and P. Moore, “AIDS-Associated Kaposi’s Sarcoma,” Science, 267 (1995), p. 1078.
> Channel 4, UK, “AIDS Now: Is There Going to be a Heterosexual Epidemic?,” Meditel Productions, London, February 5, 1988.
> Channel 4, UK, “The AIDS Catch,” Meditel Productions, London, 1990.
> Channel 4, UK, “AZT – Cause For Concern,” Meditel Productions, London, 1992.
> Channel 4, UK, “AIDS and Africa,” Meditel Productions, London, 1993.
> Chernov, H. I., Document on New Drug Application 19-655, Food and Drug Administration, Washington, D.C., 1986.
> Chieco-Bianci, L. and G. B. Rossi, “Duesberg Rights and Wrongs,” Nature, 364 (1993), p. 96.
> Chiu, D. and P. H. Duesberg, “The Toxicity of Azidothymidine (AZT) on Human and Animal Cells in Culture at Concentrations Used for Antiviral Therapy,” Genetica, 95 (1995), pp. 103-109.
> Chorba, T. L., et al., “Changes in longevity and causes of death among person with hemophilia A,” American Journal of Hematology, 45 (1994), pp. 112-121.
> Clark, S. J., et al., “High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-infection,” New England Journal of Medicine, 324 (1991), pp. 954- 906.
> Clifford, D. B., et al., “Neuropsychometric performance of asymptomatic HIV-infected subjects,” AIDS, 4 (1990), pp. 767-774.
> Clinton, W., The National Drug Control Strategy: 1996, The White House, Washington, D.C., 1996.
> Coffin, J., et al., “Human Immunodeficiency Viruses,” Science, 232 (1986), p. 697.
> Cohen, J., “Mystery Virus meets the Skeptics,” Science, 257 (1992), pp. 1032-1034.
> Cohen, J., Science, 259 (1993), pp. 168-170.
> Cohen, J., “Keystone’s blunt message: ‘It’s the virus, stupid,’” Science, 260 (1993), pp. 292-293.
> Cohen, J., “Is a New Virus the Cause of KS?,” Science, 266 (1994), pp. 1803-1804.
> Cohen, J. “Researchers Air Alternative Views on How HIV Kills Cells,” Science, 269 (1995), pp. 1044-1045.
> Cohen, S. S., “Antiretroviral Therapy for AIDS,” New England Journal of Medicine, 317 (1987), p. 629.
> Colebunders, R., et al., “Evaluation of a clinical case definition of Acquired Immunodeficiency Syndrome in Africa,” Lancet, i (1987), pp. 494-494.
> Collier, A. C., et al., “Cytomegalovirus infection in homosexual men,” American Journal of Medicine, 82 (1987), pp. 593-601.
> Collier, A. C., et al., "A pilot study of low-dose zidovudine in human immunodeficiency virus infection," New England Journal of Medicine, 323 (1990), pp. 1015-1021.
> Condon, G., “The Assault on Germs,” San Francisco Chronicle, July 28, 1993.
> Conner, S., “One Year in Pursuit of the Wrong Virus,” New Scientist, January 13, 1987, pp. 49-58.
> Conner, S., “AIDS: Science Stands on Trial,” New Scientist, February 12, 1987, pp. 49-58.
> Connor, S., “Million pound row over AIDS test,” The Independent on Sunday, January 20, 1991.
> Connor, S., “Scientists dispute royalties on HIV blood-test patent,” The Independent, August 14, 1992.
> Connor, E. M., et al., “Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type I with Zidovudine Treatment,” New England Journal of Medicine, 331 (1994), pp. 1173-1180.
> Coombs, R. W., et al., “Plasma Viremia in Human Immunodeficiency Virus Infection,” New England Journal of Medicine, December 14, 1989.
> Cooper, E. C., “Medical Officer Review of NDA 19-655,” January 27, 1988.
> Cooper, E. C., “Addendum #1 to Medical Officer Review of NDA 19-655,” March 16, 1987.
> Cotton, P., “Cofactor Question Divides Discoverers of HIV,” Medical News and Perspectives, 264 (1990), pp. 3111-3112.
> Cotton, P., “Trial Halted After Drug Cuts Maternal HIV Transmission Rate by Two-Thirds,” Journal of the American Medicine Association, 271 (1994), p. 807.
> Coulter, H., AIDS and Syphilis: The Hidden Link, North Atlantic Books, California, 1987.
> Cowley, G., “Is a New AIDS Virus Emerging?,” Newsweek, July 24, 1992, p. 41.
> Cox, G. D., “County Health Panel Urges ‘Poppers’ Ban, Cites AIDS Link,” Los Angeles Daily Journal, March 24, 1986.
> Cox, T. C., et al., Drugs and Drug Abuse, Addiction Research Foundation, Toronto, Canada, 1983.
> Craddock, M., “'Some mathematical consideration of HIV and AIDS,” AIDS: Virus or Drug Induced?, p. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Craddock, M., “A critical appraisal of the Vancouver men's study,” AIDS: Virus or Drug Induced?, p. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Craib, K. J. P., et al., “HIV causes AIDS: a controlled study,” VIII International Conference on AIDS/III STD World Congress, Amsterdam, 1992.
> Creagh-Kirk, T., et al., “Survival Experience Among Patients with AIDS Receiving Zidovudine: Follow-up of Patients in a Compassionate Plea Program,” Journal of the American Medical Association, 25 (1988).
> Cretton, E. M., et al., “Catabolism of 3’-azido-3’deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3’-amino-3’-deoxythymidine, a highly toxic catabolite for human bone marrow cells,” Molecular Pharmacology, 39 (1991), pp. 258-266.
> Crewdson, J., “Studies Hint AIDS Spread Less Severe Than Predicted,” Chicago Tribune, June 1, 1987.
> Crewdson, J., “The Great AIDS Quest,” Chicago Tribune, November 19, 1989.
> Crewdson, J., “Virus from AIDS Lab Sold, Probe Suggests,” Chicago Tribune, April 29, 1990.
> Crewdson, J., “House critique triggers another Gallo inquiry,” Chicago Tribune, June 14, 1992.
> Crewdson, J., “Ex-Gallo Aide Guilty of Pocketing $25,000,” Chicago Tribune, July 8, 1992.
> Crewdson, J., “Burden of Proof: Gallo Case Spotlights a Key Question: Can U.S. Science Be Believed?,” Chicago Tribune, December 6, 1992.
> Crewdson, J., “In Gallo Case, Truth Termed a Casualty,” Chicago Tribune, January 1, 1995.
> Crewdson, J., Science Fictions: A Scientific Mystery, a Massive Cover-up and the Dark Legacy of Robert Gallo, Back Bay Books, 2003.
> Culliton, B. J., “NIH goes 'extra mile' on Gallo,” Science, 247 (19900, p. 908.
> Culliton, B. J., “Deja vu in AIDS priority fight,” Science, 247 (1990), pp. 1532-1533.
> Culliton, B. J., “Inside the Gallo Probe,” Science, 248 (1990), pp. 1494-1498.
> Culliton, B. J., “Dingell: Aids researcher in conflict,” Science, 248 (1990), pp. 676-677.
> Culliton, B. J., “Inside the Gallo probe,” Science, 248 (1990), pp. 1494-1498.
> Culliton, B. J., “Gallo inquiry takes puzzling new turn,” Science, 250 (1990), pp. 202-203.
> Culliton, B. J., “Gallo Reports Mystery Break-in,” Science, 250 (1990), p. 502.
> Culver, K. W., et al., “Lymphocyte Abnormalities in Infants Born to Drug-Abusing Mothers,” Journal of Pediatrics, 111 (1987), pp. 230-235.
> Curran, J., et al., “Acquired immunodeficiency syndrome (AIDS) associated with transfusions,” New England Journal of Medicine, 310 (1984), pp. 69-75.
> Curran, J. W., et al., “The Epidemiology of AIDS: Current Status and Future Prospects,” Science, 229 (1985), pp. 1352-1357.

D

> Daar, E. S., et al., “Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type I Infection,” New England Journal of Medicine, 324 (1991), pp. 961-964.
> Dalakas, M. C., et al., Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy,” New England Journal of Medicine, 322 (1990), pp. 1098-1105.
> Darby, S. C., et al., “Incidence of AIDS and excess mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centers in the United Kingdom,” British Medical Journal, 298 (1989), pp. 1064-1068.
> Darby, S. C., et al., “Mortality Before and After HIV Infection in the Complete UK Population of Hemophiliacs,” Nature, 377 (1995), pp. 79-82.
> Darrow, W. W., et al., “Risk Factors for Human Immunodeficiency Virus (HIV) Infections in Homosexual Men,” American Journal of Public Health, 77 (1987), pp. 479-483.
> Day, K., “After AIDS, Superbugs Give Medicine the Jitters,” International Herald Tribune, June 28, 1995.
> Day, M., “Hype, Hope and HIV,” New Scientist, 151 (1996), pp. 28-31.
> De Biasi, R., et al., “The impact of a very high purity of factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate,” Blood, 78 (1991), pp. 1919-1992.
> De Cock, K. M. et al., “AIDS Surveillance in Africa: a reappraisal of case definitions,” British Medical Journal, 303 (1991), pp. 1185-1188.
> Deer, B., “Revealed: Fatal Flaws of Drug that Gave Hope,” Sunday Times (London), April 16, 1989.
> Delaney, M., et al., Strategies for Survival: A Gay Man’s Health Manual for the Age of AIDS, St. Martin’s Press, New York, 1987.
> Delaney, M., “’The Duesberg Phenomenon’: Duesberg and Other Voices,” Science, 267 (1995), p. 314.
> Delaney, M., “Apology,” Science, 268 (1995), p. 17.
> DeLoughry, T. J., “40 Scientists call on colleagues to re-evaluate AIDS theory,” The Chronicle of Higher Education, December 4, 1991.
> Des Jarlais, D. C., et al., “Development of AIDS, HIV Seroconversion, and Potential Cofactors for T4 Cell Loss in a Cohort of Intravenous Drug Users,” AIDS, 1 (1987), pp. 105-111.
> Des Jarlais, D. C., et al., “Risk reduction of the acquired immunodeficiency syndrome among intravenous drug users,” in AIDS and IV Drug Abusers: Current Perspectives, R.P. Galea, B.F. Lewis, L. Baker (Editors), National Health Publishing, Maryland (1988), pp. 97-109.
> Des Jarlais, D. C., et al., “CD4 Lymphocytopenia Among Injecting Drug Users in New York City,” Journal of Acquired Immune Deficiency Syndrome, 6 (1993), pp. 82-822.
> Detels, R., et al., “Patterns of CD4+ cell changes after HIV-I infection indicates the existence of a codeterminant of AIDS,” Journal of Acquired Immune Deficiency Syndromes, I (1988), pp. 390-395.
> Dickson, D., “Critic still lays blame for AIDS on lifestyle, not HIV,” Nature (London), 369 (1994), p. 434.
> Dingell, J. D., “AIDS Prevention Act of 1990,” House Committee on Energy and Commerce, May 31, 1990.
> Dingell, J. D., “Shattuck Lecture: Misconduct in Medical Research,” New England Journal of Medicine, 328 (1993), p. 1613.
> Dingell, Rep. J., Chairman, Report by the Subcommittee on Oversight and Investigations of the House of Representatives, 1994.
> Dismukes, W. E., et al., “Viral Hepatitis Associated with Illicit Parenteral Use of Drugs,” Journal of the American Medical Association, 206 (1968), pp. 1048-1052.
> Don, P. C., et al., “Nail dyschromia associated with zidovudine,” Annals of Internal Medicine, 112 (1990), pp. 145-146.
> Donahoe, R. M., et al., “Mechanistic Implications of the Findings that Opiates and Other Drugs of Abuse Moderate T-cell Surface Receptors and Antigenic Markers,” Annals of the New York Academy of Sciences, 496 (1987), pp. 711-721.
> Dournon, E., et al., “Effects of Zidovudine in 365 Consecutive Patients with AIDS or AIDS-related Complex,” Lancet, ii (1988), pp. 1297-1302.
> Drew, W. L., et al., “Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men,” Annals of Internal Medicine, 103 (1985), pp. 61-62.
> Drotman, D. P. and H. W. Haverkos, “What Causes Kaposi’s Sarcoma? Inquiring Epidemiologists Want To Know,” Epidemiology, 3 (1992), pp. 191-193.
> Drotman, D. P., et al., “Kaposi's Sarcoma. How Can Epidemiology Help Find the Cause?,” Dermatoepidemiology, 13 (1995), pp. 575-582.
> Dube, M. P., et al., American Journal of Medicine, 93 (1992), pp. 520-524.
> Dubin, G. and M. N. Braffman, “Zidovudine-induced Hepatoxicity,” Annals of Internal Medicine, 110 (1989), pp. 85-86.
> Duesberg, P. H., “Retroviruses as Carcinogens and Pathogens: Expectations and Reality,” Cancer Research, 47 (1987), pp. 1199-1220.
> Duesberg, P. H., “HIV is not the cause of AIDS,” Science, 241 (1988), pp. 514-516.
> Duesberg, P. H., “Defective viruses and AIDS,” Nature (London), 340 (1989), p. 515.
> Duesberg, P. H., “Does HIV Cause AIDS?,” Journal of Acquired Immune Deficiency Syndrome, 2 (1989), pp. 514-515.
> Duesberg, P. H., “Human immunodeficiency virus and acquired immunodeficiency syndrome: Correlation but not causation,” Proceedings of the National Academy of Sciences USA, 86 (1989), pp. 755-764.
> Duesberg, P. H., “Responding to ‘The AIDS Debate’,” Naturwissenschaften, 77 (1990), pp. 97-102.
> Duesberg, P. H., “Quantitation of Human Immunodeficiency Virus in the blood,” New England Journal of Medicine, 322 (1990), p. 1466.
> Duesberg, P. H., “AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease,” Proceedings of the National Academy of Sciences USA, 88 (1991), pp. 1575-1579.
> Duesberg, P. H., “Can alternative hypotheses survive in this era of megaprojects?,” The Scientist, July 8, 1991.
> Duesberg, P. H., “AIDS acquired by drug consumption and other noncontagious risk factors,” Pharmacology & Therapeutics, 55 (1992), pp. 201-277.
> Duesberg, P. H., “A giant hole in the HIV-AIDS hypothesis,” The Sunday Times, May 31, 1992.
> Duesberg, P. H., “The role of drugs in the origin of AIDS,” Biomed Pharmacother, 46 (1992), pp. 3-15.
> Duesberg, P. H., “HIV as target for zidovudine,” Lancet, 339 (1992), p. 551.
> Duesberg, P. H., “HIV, AIDS, and zidovudine,” Lancet, 339 (1992), pp. 805-806.
> Duesberg, P. H., “HIV and AIDS,” Science, 260 (1993), p. 1705.
> Duesberg, P. H., “Can epidemiology determine whether drugs or HIV cause AIDS?,” AIDS-Forschung, 12 (1993), pp. 627-635.
> Duesberg, P. H., “Aetiology of AIDS,” Lancet, 341 (1993), pp. 957-958.
> Duesberg, P. H., “The Enigma of Slow Viruses,” Lancet, 342 (1993), p. 720.
> Duesberg, P. H., “The HIV gap in national AIDS statistics,” Biotechnology, II (1993), pp. 955-956.
> Duesberg, P. H., “Infectious AIDS – stretching the germ theory beyond its limits,” International Archives of Allergy and Applied Immunology, 103 (1994), pp. 131-142.
> Duesberg, P. H., “Results fall short for HIV theory,” Insight, 10, February 14 (1994), pp. 27-29.
> Duesberg, P. H., Infectious AIDS: Have We Been Misled?, North Atlantic Books, Berkeley, 1995.
> Duesberg, P. H., “Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV,” Genetica, 95 (1995), pp. 51-70.
> Duesberg, P. H. and J. Yiamouyiannis, AIDS: The good news is HIV doesn't cause it; the bad news is recreational drugs and medical treatments like AZT do, Health Action Press, 1995.
> Duesberg, P. H., “How much longer can we afford the AIDS virus monopoly?,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Duesberg, P. H., “Duesberg Defends Challenges to the Existence of HIV: Article 1 of 2,” Continuum, 4 (2) (1996), pp. 8-9.
> Duesberg, P. H., Inventing the AIDS Virus, Regnery Publishing, Washington, D.C., 1996.
> Duesberg, P. H., “Duesberg Defends Challenges to the Existence of HIV: Article 2 of 2,” Continuum, 4 (5) (1997), p. 26.
> Duesberg, P. H., and B. J. Ellison, “Is the AIDS virus a science fiction,” Policy Review, 53 (1990), pp. 40-51.
> Duesberg, P. H. and J. R. Schwartz, “”Latent viruses and mutated oncogenes: no evidence for pathogenicity,” Prog Nucleic Acid Res Mol Biol, 43 (1992), pp. 135-204.
> Duesberg, P. and H. Bialy, “Duesberg and the Right of Reply According to Maddox – Nature,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Duesberg, P. H. and D. Rasnick, “The AIDS dilemma: Drug Diseases Blamed on a Passenger Virus,” Genetica, 104 (1998), pp. 85-132.
> Duesberg, P. H., et al., “The Chemical Bases of the Various AIDS Epidemics: Recreational Drugs, Anti-viral Chemotherapy and Malnutrition,” Journal of Biosciences, 28 (2003), pp. 383-412.
> Duncan, R. A., et al., New England Journal of Medicine, 328 (1993), pp. 393-398.

E

> Edlin, B. R., et al., “Intersecting Epidemics – Crack Cocaine Use and HIV Infection Among Inner-City Young Adults,” New England Journal of Medicine, 331 (1994), pp. 1422-1427.
> Eggers, H. J. and J. J. Weyer, “Linkage and independence of AIDS Kaposi disease: the interaction of Human Immunodeficiency Virus and some coagents,” Infection, 19 (1991), pp. 115-122.
> Eigen, M., “The AIDS Debate,” Naturwissenschaften, 76 (1989), pp. 341-350.
> Ellison, B. J., et al., “HIV as a Surrogate Marker for Drug-use: A Re-analysis of the San Francisco Men's Health Study,” Genetica, 95 (1995), pp. 165-171.
> Elwell, L. P., et al., “Antibacterial Activity and Mechanism of Action of 3'-azido-3'- deoxythymidine (BW A509U),” Antimicrobial Agents Chemotherapy, 31 (1987), pp. 274-280.
> Ensoli, B., et al., “Tat protein of HIV-I stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patients,” Nature (London), 345 (1990), pp. 84-86.
> Epstein, S., Impure Science: AIDS, Activism, and the Politics of Knowledge (Medicine and Society), University of California Press, 1996.
> Erlichman, J., “Welcoming Some Nice, Easy Profits from AIDS Monopoly,” Guardian, October 23, 1987.
> Espinoza, P., et al., “High Prevalence of Infection by Hepatitis B Virus and HIV in Incarcerated French Drug Addicts,” Gastroenterologie Clinique et Biologique, 11 (1987), pp. 288-292.
> European Collaborative Study, “Children born to women with HIV-I infection: natural history and risk of transmission,” Lancet, 337 (1991), pp. 253-260.
> European Collaborative Study, “Natural History of Vertically Acquired Human Immunodeficiency Virus-I Infection,” Pediatrics, 94 (1994), pp. 815-819.
> Evans, A. S., “Does HIV Cause AIDS? An Historical Perspective,” Journal of Acquired Immune Deficiency Syndrome, 2 (1989), pp. 107-113.
> Evans, A. S., et al., Viral Infections of Humans, Epidemiology and Control, Plenum Publishing Corporation, New York, 1989.
> Evans, A. S., et al., “AIDS: the alternative view,” Lancet, 339 (1992), p. 1547.
> Evatt, B., et al., “The acquired immunodeficiency syndrome in patients with hemophilia,” Annals of Internal Medicine, 100 (1984), pp. 499-505.
> Evatt, B., et al., “Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic,” New England Journal of Medicine, 312 (1985), pp. 483-486.
> Eyster, M. E. and M. E. Nau, “Particulate material in antihemophiliac factor (AHF) concentrates,” Transfusion (September-October, 1978), pp.576-581.
> Eyster, M. E., et al., “Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia,” Blood, 66 (1985), pp. 1317-1320.

F

> Farber, C., “Sins Of Omission: The AZT Scandal,” Spin, November 1989.
> Farber, C., “AIDS: Words from the Front,” Spin, April 1991.
> Farber, C., “AIDS: Words from the Front,” Spin, September 1992.
> Farber, C., “Out of Africa, Part I,” Spin, March 1993.
> Farber, C., “AIDS: Words from the Front,” Spin, July 1994.
> Farber, C., “AZT is Death,” Spin, August 1993.
> Farber, C., “AIDS: Words from the Front,” Spin, July 1995.
> Farber, C., “AIDS: Words from the Front,” Spin, September 11, 1995.
> Farber, C., 'The HIV test,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Fauci, A. S., “The role of the endogenous cytokines in the regulation of HIV expression,” HIV Advanced Research Therapies, 1 (1991), pp. 3-7.
> Fauci, A. S., “CD4+ T-lymphocytopenia without HIV infection – no lights, no camera, just facts,” New England Journal of Medicine, 328 (1993), pp. 429-431.
> Fee, E. and D. M. Fox (Editors), AIDS: The Making of a Chronic Disease, University of California Press, Berkeley, 1992.
> Fields, B. N., “AIDS: time to turn to basic science,” Nature (London), 369 (1994), pp. 95-96.
> Fineberg, H. V., “The Social Dimensions of AIDS,” Scientific American, 259 (1988), pp. 128-134.
> Fischl, M. A., et al., “The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex,” New England Journal of Medicine, 317 (1987), pp. 185-191.
> Fischl, M. A., et al., “Prolonged zidovudine therapy in patient with AIDS and advanced AIDS-related complex,” Journal of the American Medical Association, 262 (1989), pp. 2405-2410.
> Fletcher, M. A., et al., “Effect of Age on Human Immunodeficiency Virus Type I – induced Changes in Lymphocyte Populations Among Persons with Congenital Cloning Disorders,” Blood, 80 (1992), pp. 831-840.
> Fogelman, I., et al., “Prevalence and Patterns of Use of Concomitant Medications Among Participants in Three Multicenter Human Immunodeficiency Virus Type I Clinical Trials,” Journal of Acquired Immune Deficiency Syndromes, 7 (1994), pp. 1057-1063.
> Francis, D. P., “The search for the cause,” in The AIDS Epidemic, K.M. Cahill (Editor), St. Martin’s Press, New York, 1983, pp. 137-148.
> Francis, D. P., et al., “Epidemic acquired immune deficiency syndrome: epidemiological evidence for a transmissible agent,” Journal of the National Cancer Institute, 71 (1983), pp. 1-4.
> Francis, D., “Toward a Comprehensive HIV Prevention Program for the CDC and the Nation,” Journal of the American Medical Association, 268 (1993), pp. 1444-1447.
> Freeman, B. A., Burrows Textbook of Microbiology, W. B. Saunders Company, Philadelphia, 1979.
> Freestone, D. S., “Zidovudine,” Lancet, 339 (1992), p. 626.
> Freiman, J. P., et al., “Hepatomegaly with Severe Steatosis in HIV-seropositive Patients,” AIDS, 7 (1993), pp. 379-385.
> Friedland, G. H., et al., “Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis,” New England Journal of Medicine, 314 (1986), pp. 344-349.
> Friedman-Kien, A. E., et al., “Kaposi’s Sarcoma in HIV-negative Homosexual Men,” Lancet, 335 (1990), pp. 168-169.
> Froebel, K. S., et al., “Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?,” British Medical Journal, 287 (1983), pp. 1091-1093.
> Fry, T. C., The Great AIDS Hoax, Life Science Institute, Texas, 1989.
> Fultz, P. N., et al., “Humoral response to SIV/SMM infection in macaque and mangabey monkeys,” Journal of Acquired Immune Deficiency Syndrome, 3 (1990), pp. 319-329.
> Fumento, M., The Myth of Heterosexual AIDS, Basic Books, New York, 1989.
> Furman, P. A.m, et al., “Phosphorylation of 3’-azido-3’-deoxythymidine and Selective Interaction of the 5’-triphosphate with Human Immunodeficiency Virus Reverse Transcriptase,” Proceedings of the National Academy of Sciences USA, 83 (1986), pp. 8333-8337.

G

- Gallo, R.C., "Antigens on HTLV-Infected Cells Recognized by Leukaemia and AIDS Sera are Related to HTLV Viral Glycoprotein," Science, May 11, 1984.
> Gallo, R.C., “Mechanism of Disease Induction by HIV,” Journal of Acquired Immune Deficiency Syndrome, 3 (1990), pp. 380-389.
> Gallo, R.C., Virus Hunting - AIDS, Cancer, and the Human Retrovirus: A Story of Scientific Discovery, Basic Books, New York, 1991.
> Gallo, R. C. and L. Montagnier, “The chronology of AIDS research,” Nature (London), 326 (1987), pp. 435-436.
> Gallo, R. C. and L. Montagnier, “AIDS in 1988,” Scientific American, 259 (1988), pp. 40-48.
> Gallo, R. C., et al., “Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS),” Science, 220 (1983), pp. 865-867.
> Gallo, R. C., et al., “Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS,” Science, 224 (1984), pp. 500-503.
> Garbulgia, A. R., et al., “In Vitro Activation of HIV RNA Expression in Peripheral Blood Lymphocytes as a Marker to Predict the Stability of Non-progressor Status in Long-term Survivors,” AIDS, 10 (1996), pp. 17-21.
> Garrett, L. “AIDS: The Next Decade,” New York Newsday, June 12, 1990.
> Garry, R. F., et al., “Documentation of an AIDS Virus Infection in the United States in 1968,” Journal of the American Medical Association, 260 (1988), pp. 2085-2087.
> Garry, R. F., et al., “Similarities of viral proteins to toxins that interact with monovalent cation channels,” AIDS, 5 (1991), pp. 1381-1384.
> Gavzer, B., “What We Can Learn from Those Who Survive AIDS,” Parade, June 10, 1990.
> Gavzer, B., “Love Has Helped Keep Me Alive,” Parade Magazine, April 16, 1995, pp. 4-6.
> Geller, S. A. and B. Stimmel, “Diagnostic Confusion from Lymphatic Lesions in Heroin Addicts,” Internal Medicine, 78 (1973), pp. 703-705.
> Gibbons, J., “Drugs & Us,” Gay Times (London), September 1996, pp. 17-37.
> Gilden, Raymond V., “HTLV-III Legend Corrected,” Science, April 18, 1986, p. 307.
> Gilks, C., “What use is a clinical case definition for AIDS in Africa?,” British Medical Journal, 303 (1991), pp. 1189-1190.
> Gill, J. C., et al., “HTLV-III serology in hemophilia: Relationship with immunological abnormalities,” Journal of Pediatrics, 108 (1986), pp. 511-516.
> Gill, P. S., et al., “Azidothymidine Associated with Bone Marrow Failure in the Acquired Immunodeficiency Syndrome (AIDS),” Annals of Internal Medicine, 107 (1987), pp. 502-505.
> Ginzburg, H. M., et al., “Acquired immune deficiency syndrome (AIDS) and drug abuse,” in AIDS and I.V. Drug Abusers Current Perspectives, R.P. Galea, B.F. Lewis, and L. Baker (Editors), National Health Publishing, Maryland, 1988, pp. 61-73.
> Gjerset, G. E., et al., “Effect of Low- and Intermediate-Purity Cloning Factor Therapy on Progression of Human Immunodeficiency Virus Infection in Congenital Cloning Disorders,” Blood, 84 (1994), pp. 1666-1671.
> Goedert, J. J., et al., “Amyl Nitrite May Alter T Lymphocytes in Homosexual Men,” Lancet, i (1982), pp. 412-416.
> Goedert, J. J., et al., “A prospective study of human immunodeficiency virus type I infection and the development of AIDS in subjects with hemophilia,” New England Journal of Medicine, 321 (1989), pp. 1141-1448.
> Goedert, J. J., et al., “Risks of Immunodeficiency, AIDS, and Death Related to Purity of Factor VIII Concentrate,” Lancet, 344 (1994), pp. 791-792.
> Goldsmith, J. M. et al., “CD4 Cells in HIV-I Infected Hemophiliacs: effect of Factor VIII concentrates,” Journal of Thrombosis and Haemostasis, 66 (1991), pp. 415-419.
> Goldsmith, M. S., “Science ponders whether HIV acts alone or has another microbe’s aid,” Journal of the American Medical Association, 264 (1990), pp. 265-266.
> Gomperts, E. D., et al., “The Impact of Cloning Factor Concentrates on the Immune System in Individuals with Hemophilia,” Transfusion Medicine Reviews, 6 (1992), pp. 44-54.
> Goodgame, R. W., “AIDS in Uganda – clinical and social features,” New England Journal of Medicine, 323 (1990), pp. 383-389.
> Gorard, D. A., and R. J. Guillodd, “Necrotising myopathy and zidovudine,” Lancet, i (1988), p. 1050.
> Gordon, R. S., “Factor VIII products and disordered immune regulation,” Lancet, i (1983), p. 991.
> Gorman, C., Time, March 22, 1993, p. 49.
> Gorman, P., “Peter Duesberg: Visionary or Public Menace?,” High Times, December 1994, pp. 58-61, 66.
> Gottlieb, M.S., et al., “Pneumocystis Pneumonia - Los Angeles,” Centers for Disease Control, Morbidity and Morality Weekly Report 30 (June 5, 1981), pp. 250-252.
> Goudsmit, J., “Alternative View on AIDS,” Lancet, 339 (1992), pp. 1289-1290.
> Graham, N. M. Z., et al., “Effect of Zidovudine and Pneumocystis Carinii Pneumonia Prophylaxis on Progression of HIV-I Infection to AIDS,” Lancet, 338 (1991), pp. 265-269.
> Greenblatt, R. M., et al., “Polypharmacy Among Patients Attending an AIDS Clinic: Utilization of Prescribed, Unorthodox, and Investigational Treatments,” Journal of Acquired Immune Deficiency Syndromes, 4 (1991), pp. 136-143.
> Greenberg, D. S., “Saint or Scoundrel? The Gallo Controversy Goes On,” Science and Government Report, February 1, 1994, p. 6.
> Griffin, B. E., “Burden of Proof,” Nature, 338 (1989), p. 670.
> Grimshaw, J., “Being HIV antibody-positive,” British Medical Journal, 295 (1987), pp. 256-257.
> Groopman, J., et al., “HTLV-III in Saliva of People with AIDS-Related Complex and Healthy Homosexual Men at Risk for AIDS,” Science, October 24, 1984, pp. 447-449.
> Group for the Scientific Reappraisal of the HIV-AIDS Hypothesis, Rethinking AIDS newsletter (also titled Reappraising AIDS), all issues, beginning February 1996, Chico, CA.
> Guinan, M. E. and A. Hardy, “Epidemiology of AIDS in women in the United States, 1981 through 1986,” Journal of the American Medical Association, 257 (1987), pp. 2039-2042.
> Gupta, S., et al., Proceedings of the National Academy of Sciences USA, 89 (1992), pp.7831-7835.

H

> Haas, M., “The need for a search for a proximal principle of human AIDS,” Cancer Research, 49 (1989), pp. 2184-2187.
> Hahn, B. H., et al., “Genetic variation in HTLV-III/LAV over time with patients with AIDS or at risk for AIDS,” Science, 232 (1986), pp. 1548-1553.
> Hall, C. T., “AIDS Advances Boost Drugmaker,” San Francisco Chronicle, August 1, 1996.
> Hall, S., “David Baltimore’s Final Days,” Science, 254 (1991), pp. 1576-1579.
> Hall, S. S., “Gadfly in the Ointment,” Hippocrates, September/October 1988, p. 80.
> Hamilton, D. P., “What Next in the Gallo Case?,” Science, 254 (1991), pp. 941-945.
> Hamilton, J. D., et al., “A Controlled Trial of Early Versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection,” New England Journal of Medicine, 326 (1992), pp. 437-443.
> Hand, T. H., “Forced H.I.V. Testing Won’t Help newborns; Flaws in AZT Studies,” New York Times, July 22, 1995.
> Hand, T. H., “Antiviral Drugs Versus Long-term Survival: Why Antiviral Drugs Cannot Resolve AIDS,” Reappraising AIDS, 4 (1996), pp. 1-4.
> Hardy, A. M., et al., “The incidence rate of acquired immunodeficiency syndrome in selected populations,” Journal of the American Medical Association, 253 (1985), pp. 215-220.
> Harrer, T., et al., “Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type I Infection,” AIDS Research and Human Retroviruses, 12 (1996), pp. 585-592.
> Harris, F., “AIDS and good theory-making,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Harris, P. D. and R. Garret, “Susceptibility of Addicts to Infection and Neoplasia,” New England Journal of Medicine, 287 (1972), p. 310.
> Haseltine, W. A. and F. Wong-Staal, “The molecular biology of the AIDS virus,” Scientific American, 259 (1988), pp. 52-62.
> Hassett, J., et al., “Effect of Lymphocyte Subsets of Cloning Factor Therapy in Human Immunodeficiency Virus-I-Negative Congenital Cloning Disorders,” Blood, 82 (1993), pp. 1351-1357.
> Hauptman, L., “Statistical Review and Evaluation,” NDA 19-655/Drug Class 1A, Burroughs-Wellcome Company, AZT Capsules, p. 17.
> Haverkos, H. W., “Epidemiological studies – Kaposi’s sarcoma vs opportunistic infections among homosexual men with AIDS,” in Health Hazards of Nitrite Inhalants, H.W. Haverkos and J.A. Dougherty (Editors), NIDA Research Monograph 83, U.S. Department of Health and Human Services, Washington, D.C., 1988.
> Haverkos, H. W., “Kaposi’s sarcoma and nitrite inhalants,” in Psychological, Neuropsychiatric and Substance Abuse Aspects of AIDS, T.P. Bridge, A.F. Mirsky, and F.K. Goodwin (Editors), Raven Press, New York, 1988, pp. 165-172.
> Haverkos, H. W., “Nitrite Inhalant Abuse and AIDS-Related Kaposi’s Sarcoma,” Journal of Acquired Immune Deficiencies, 3 (1990), Supplement 1, pp. S47-S50.
> Haverkos, H. W. and J. A. Doughtery, Editors, Health Hazards of Nitrite Inhalants, NIDA Research Monograph 83, U.S. Department of Health and Human Services, Washington, D.C., 1988.
> Haverkos, H. W. and D. P. Drotman, “Measuring inhalant nitrite exposure in gay men: implications for elucidating the etiology of AIDS-related Kaposi's sarcoma,” Genetica, 95 (1995), pp. 157-164.
> Haverkos, H. W., et al., “Disease manifestation among homosexual men with acquired immunodeficiency syndrome: a possible role of nitrites in Kaposi’s sarcoma,” Journal of Sexually Transmitted Diseases, 12 (1985), pp. 20-3-208.
> Hayes, T., et al., “HIV-related Deaths from Selected Infectious Diseases Among Persons Without AIDS in New Jersey,” Journal of Acquired Immune Deficiency Syndrome, 7 (1994), pp. 1074-1078.
> Hearst, N. and S. Hulley, “Preventing the heterosexual spread of AIDS: are we giving our patients the best advice?,” Journal of the American Medical Association, 259 (1988), pp. 2428-2432.
> Helbert, M., et al., “Zidovudine-associated myopathy,” Lancet, ii (1988), pp. 689-690.
> Hersh, E. M., et al., “Effect of the recreational agent isobutyl nitrite on human peripheral blood leukocytes and on in vitro interferon production,” Cancer Research, 43 (1983), pp. 1365-1371.
> Heyward, W. L. and J. W. Curran, “The Epidemiology of AIDS in the U.S.,” Scientific American, 259 (1988), pp. 72-81.
> Hilgartner, M. W., et al., “Purity of factor VIII concentrates and serial CD4 counts,” Lancet, 341 (1993), pp. 1373-1374.
> Hilton, B., “CDC Accused of Alarming the Public,” San Francisco Examiner, February 10, 1991.
> Hilts, P. J., “AIDS Drug Causes Cancer in Animals,” New York Times, December 6, 1989.
> Hilts, P. J., “Monkey's HIV Vulnerability Portends AIDS Breakthrough,” New York Times, June 12, 1992.
> Hishida, O., et al., “Clinically diagnosed AIDS cases without evident association with HIV type 1 and 2 infection in Ghana,” Lancet, 340 (1992), pp. 971-972.
> Hitchcock, M. J. M., “Review: Antiviral Portrait Series, Number 1; 2',3'-didehydro-2',3'- dideoxythymidine (D4T), and Anti-HIV Agent,” Antiviral Chemistry in Chemotherapy, 2 (1991), pp. 125-132.
> Ho, D. D., et al., “Infrequency of Isolation of HTLV-III Virus from Saliva in AIDS,” New England Journal of Medicine (1985), p. 1606.
> Ho, D. D., et al., “Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Person,” New England Journal of Medicine, 321 (1989), pp. 1621-1625.
> Ho, D. D., et al., “Human immunodeficiency virus type I in a seronegative patient with visceral Kaposi’s sarcoma and hypogammaglobulinemia,” American Journal of Medicine, 86 (1989), pp. 349-351.
> Ho, D. D., et al., New England Journal of Medicine, 328 (1993), pp. 380-385.
> Ho, D. D., et al., “Rapid Turnover of Plasma Virions and CD4 Lymphocytes in HIV-I Infection,” Nature, 373 (1995), pp. 123-126.
> Hodgkinson, N., “Experts mount startling challenge to AIDS orthodoxy/AIDS; Can we be positive?,” The Sunday Times (London), April 26, 1992.
> Hodgkinson, N., “Government to back rebels in AIDS research,” The Sunday Times (London), May 3, 1992.
> Hodgkinson, N., “AIDS rebel blames scientists for deaths,” The Sunday Times (London), May 17, 1992.
> Hodgkinson, N., “The truth is, we don't know what causes this disease,” The Sunday Times (London), July 26, 1992.
> Hodgkinson, N., “Factor 8 hope in HIV battle,” The Sunday Times (London), February 22, 1993.
> Hodgkinson, N., “AIDS truth falls victim to virus of ignorance,” The Sunday Times (London), March 14, 1993.
> Hodgkinson, N., “Epidemic of AIDS in Africa; A tragic myth,” The Sunday Times (London), March 21, 1993.
> Hodgkinson, N., “The Cure That Failed,” The Sunday Times (London), April 4, 1993.
> Hodgkinson, N., “Experts confounded on AIDS as grim reaper fails to strike,” The Sunday Times (London), April 18, 1993.
> Hodgkinson, N., “New realism puts the brake on HIV bandwagon,” The Sunday Times (London), May 9, 1993.
> Hodgkinson, N., “How giant drug firm funds the aids lobby,” The Sunday Times (London), May 30, 1993.
> Hodgkinson, N., “New doubts over AIDS infection as HIV test declared invalid,” The Sunday Times (London), August 1, 1993.
> Hodgkinson, N., “Babies give lie to African AIDS,” The Sunday Times (London), August 29, 1993.
> Hodgkinson, N., “African AIDS; true or false?,” The Sunday Times (London), September 5, 1993.
> Hodgkinson, N., “African AIDS Plague ‘a Myth’,” The Sunday Times (London), October 3, 1993.
> Hodgkinson, N., “The plague that never was,” The Sunday Times (London), October 3, 1993.
> Hodgkinson, N., “Nobel chemist attacks HIV theory of AIDS,” The Sunday Times (London), November 28, 1993.
> Hodgkinson, N., “AIDS; Why we won't be silenced,” The Sunday Times (London), December 12, 1993.
> Hodgkinson, N., “Court Battles Launched Over Anti-AIDS Drug,” The Sunday Times (London), January 30, 1994.
> Hodgkinson, N., “Conspiracy of silence,” The Sunday Times (London), April 3, 1994.
> Hodgkinson, N., “New evidence links gay sex drug to AIDS,” The Sunday Times (London), April 10, 1994.
> Hodgkinson, N., “Research disputes epidemic of AIDS,” The Sunday Times (London), May 22, 1994.
> Hodgkinson, N., “Cry, beloved country; How Africa became the victim of a non-existent epidemic of HIV/AIDS,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Hodgkinson, N., AIDS: The Failure of Contemporary Science, Fourth Estate, London, UK, 1996.
> Hodgkinson, N. and L. Rogers, “Babies treated with contested AIDS drug,” The Sunday Times (London), June 6, 1993.
> Hogan, J. P., “AIDS Heresy In The Viricentric Universe,” from Kicking the Sacred Cow: Questioning the Unquestionable and Thinking the Impermissible, Baen Books, New York, 2004.
> Hogervorst, E., et al., “Predictors for Non- and Slow-progression in Human Immunodeficiency Virus (HIV) Type I Infection: Low Viral RNA Copy Numbers in Serum and Maintenance of High HIV-I p24-specific but not V3-specific Antibody Levels,” Journal of Infectious Diseases, 171 (1995), pp.811-821.
> Hollan, S. R., et al., “Immunological alternations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary,” Immunological Letters, II (1985), pp. 305-310.
> Holmberg, S. D., et al., “Use of Therapeutic and Prophylactic Drugs for AIDS by Homosexual and Bisexual Men in Three U.S. Cities,” Lancet (1992).
> Holub, W. R., “AIDS: A new disease?,” Amer. Clin. Prod. Review, 7 (1988), pp. 28-37.
> Hoover, D. R., et al., “Long-term Survival Without Clinical AIDS After CD4+ Cell Count Falls Below 200 x 10(6)/1,” AIDS, 9 (1995), pp. 145-152.
> Hopkins, D., “Dr. Joseph Sonnabend,” Interview Magazine, December 1992, pp. 124-126, 142-143.
> Horton, R., “Truth and Heresy about AIDS,” The New York Review 43 (1996), pp. 14, 16-20.
> Horwitz, J. P., et al., “The Monomesylates of 1-(2'-deoxy-beta-D- lyxofuranosyl)thymidine,” Journal of Organic Chemistry, 29 (1964), p. 2076.
- Howe, M, "Zerit Usage Outpaces AZT; Efficacy, Resistance Profile and Convenience Cited," PRNewswire, Princeton, N.J., January 29, 1998.
> Hoxie, J. A., et al., “Persistent Noncytopathic Infection of Normal Human T Lymphocytes with AIDS-associated Retrovirus,” Science, 229 (1985), pp. 1400-1402.
> Huang, Y. Q., et al., “HPV-16-related DNA sequences in Kaposi’s sarcoma,” Lancet, 339 (1992), pp. 515-518.
> Hughes, M. D., et al., “Within-subject Variation in CD4 Lymphocyte Count in Asymptomatic Human Immunodeficiency Virus Infection: Implications for Patient Monitoring,” Journal of Infectious Diseases, 169 (1994), pp. 28-36.
> Humphrey, L. C. (Editor), Living With AIDS, National Commission on AIDS, 1991.

I

> Institute of Medicine, Confronting AIDS: Directions for Public Health, National Academy Press, Washington, D.C., 1986.
> Institute of Medicine, Confronting AIDS - Update 1988, National Academy Press, Washington, D.C., 1988.
> Irwin, D. H. and L. D. Kaplan, “Pulmonary Manifestations of Acquired Immunodeficiency Syndrome – Associated Malignancies,” Seminars in Respiratory Infections, 8 (1993), pp. 139-148.

J

> Jackson, T., “Gambling on AIDS Drug Gives Wellcome a Happy Anniversary,” Financial Times, February 21, 1987.
> Jacquez, J. A., et al., “Role of the Primary Infection in Epidemics of HIV Infection in Gay Cohorts,” Journal of Acquired Immune Deficiency Syndrome, 7 (1994), pp. 1169-1184.
> Jaffe, H. W., et al., “Acquired Immune Deficiency Syndrome in the United States: The First 1000 Cases,” Journal of Infectious Diseases, 148 (1983), pp. 339-345.
> Jaffe, H. W., et. al., “National Case-control Study of Kaposi's Sarcoma and Pneumocystis Carinii Pneumonia in Homosexual Men: Part I, Epidemiologic Results,” Annals of Internal Medicine, 99 (1983), pp. 145-151.
> Jason, J. M., et al., “HTLV-II/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia,” Journal of the American Medical Association, 255 (1986), pp. 212-215.
> Jason, J. R., et al., “Relationship of partially purified factor concentrates to immune tests and AIDS,” American Journal of Hematology, 34 (1990), pp. 262-269.
> Jin, Z., et al., “ Immunodeficiency in patients with hemophilia: an underlying deficiency and lack of correlation with factor replacement therapy or exposure to Human Immunodeficiency Virus,” Allergy and Clinical Immunology, 83 (1989), pp. 165-170.
> Johnson, C., “Factors Known to Cause False-positive Antibody Test Results,” Continuum (London), 4 (1996), p. 5.
> Johnson, P., “The thinking problem in HIV science,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Johnson, R. E., et al., “Acquired immunodeficiency syndrome among patients attending hemophilia treatment centers and mortality experience of hemophiliacs in the United States,” American Journal of Epidemiology, 121 (1985), pp. 797-810.
> Jones, C., “AIDS: Words from the Front,” Spin, October 1991.
> Jones, J. L., et al., “AIDS-Associated Kaposi’s Sarcoma,” Science, 267 (1995), pp. 1077-1078.
> Jones, P. S., et al., “Altered immunology in haemophilia,” Lancet, i (1983), pp. 120-121.
> Jorgensen, K.A. and S. O. Lawesson, “Amylnitrite and Kaposi’s sarcoma in homosexual men,” New England Journal of Medicine, 307 (1982), pp. 893-894.
> Judson, F. N., et al., “Comparative prevalence rates of sexually transmitted diseases in heterosexual and homosexual men,” American Journal of Epidemiology, 112 (1980), pp. 836-843.

K

> Kaczmarski, R. S., et al., Lancet, 340 (1992), p. 608.
> Kaslow, R. A., et al., “Infection with Human Immunodeficiency Virus: Clinical Manifestations and Their Relationship to Immunodeficiency,” Annals of Internal Medicine 107 (1987), pp. 474-480.
> Kaslow, R. A., et al., “No Evidence for a Role of Alcohol or Other Psychoactive Drugs in Accelerating Immunodeficiency in HIV-I-Positive Individuals,” Journal of the American Medical Association, 261 (1989), pp. 3424-3429.
> Kessler, C M., et al., “Abnormal T-lymphocyte subpopulations associated with transfusions of blood-derived products,” Lancet, ii (1983), pp. 991-992.
> Kestler, H., et al., “Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus,” Science, 248 (1990), pp. 1109-1112.
> Kestler, H., et al., “Importance of the nef gene for maintenance of high virus loads and for development of AIDS,” Cell, 65 (1991), pp. 651-662.
> Kitzerow Jr., M., The AIDS Indictment, Mrkco Pub, 2000.
> Klein, G., “The role of science,” Journal of Acquired Immune Deficiency Syndrome, 1 (1988), pp. 611-615.
> Klinger, K., “Early AIDS Treatment Questioned,” United Press International, July 13, 1995.
> Koch, T. K., et al., “Developmental abnormalities in uninfected infants born to Human Immunodeficiency Virus-infected mothers,” Annals of Neurology, 28 (1990), pp. 456-457.
> Koerper, M. A., “AIDS and Hemophilia,” AIDS, Pathogenesis and Treatment, J.A,.Levy (Editor), Marcel Dekker, Inc., New York, 1989, pp. 79-95.
> Kolata, G., “Imminent Marketing of AZT Raises Problems: Marrow Suppression Hampers AZT Use in AIDS Victims,” Science, 235 (1987), pp. 1462-1463.
> Kolata, G., “After 5 Years of Use, Doubt Still Clouds Leading AIDS drug,” New York Times, June 2, 1992.
> Kolata, G., “New Picture of Who Will get AIDS is Dominated by Addicts,” New York Times, February 28, 1995.
> Koliadin, V. L., “'Critical analysis of the current views on the nature of AIDS,” Genetica, 95 (1995), pp. 71-90.
> Kono, R., “The SMON Virus Theory,” Lancet, ii (1975), pp. 370-371.
> Kono, R., “Introductory Review of Subacute Myelo-optico-neuropathy (SMON) and its Studies Done by the SMON Research Committee,” Japanese Journal of Medicine, Science and Biology, 28 (Supplement) (1975), pp. 1-21.
> Konotey-Ahulu, F. I. D., “AIDS in Africa: Misinformation and Disinformation,” Lancet (July, 1987), pp. 206-207.
> Konotey-Ahulu, F. I. D., What Is AIDS?, Tetteh-A’Domeno Co., England, 1989.
> Koury, M. J., et al., American Journal of Hematology, 35 (1990), pp. 134-135.
> Kozel, N. J. and E. H. Adams, “Epidemiology of Drug Abuse: An Overview,” Science, 234 (1986), pp. 970-974.
> Kramer, L., “Checking In, My Chart,” POZ, August/September 1994, pp. 92-93.
> Kramer, L., “A Good News/Bad News AIDS Joke,” New York Times, July 14, 1996.
> Kreiss, J. K., et al., “Nontransmission of T-cell subset abnormalities from hemophiliacs to their spouses,” Journal of the American Medical Association, 251 (1984), pp. 1450-1454.
> Kreiss, J. K., et al., “Human T Cell Leukemia Virus Type III Antibody, Lymphadenopathy, and Acquired Immune Deficiency Syndrome in Hemophiliac Subjects,” American Journal of Medicine, 80 (1986), pp. 345-350.
> Krieger, L. M. and C. A. Caceres, “The Unnoticed Link in AIDS Cases,” Wall Street Journal, October 24, 1985.
> Krieger, L. M., “Kaposi’s Sarcoma, AIDS Link Questioned,” San Francisco Examiner, June 5, 1992.
> Krieger, L. M., “An AIDS Reporter’s Open Letter to the Community,” San Francisco Chronicle, March 21, 1993.
> Krieger, L. M., “1 in 300 U.S. Adults Infected, Says Report,” San Francisco Examiner, July 7, 1996.
> Kumar, R. M., et al., “Zidovudine Use in Pregnancy: A Report on 104 Cases and the Occurrence of Birth Defects,” Journal of Acquired Immune Deficiency Syndrome, 7 (1994), pp. 1034-1039.

L

> Lambert, B., “New York Called Unprepared on AIDS,” New York Times, July 14, 1988.
> Lambert, B., “Kimberly Bergalis is dead of AIDS at 23,” New York Times, December 9, 1991.
> Land, W., et al., “Patterns of T Lymphocyte Changes with Human Immunodeficiency Virus Infection: From Seroconversion to the Development of AIDS,” Journal of Acquired Immune Deficiency Syndrome, 2 (1989), pp. 63-69.
> Landesmann, S. et al., “Sero-survey of Human Immunodeficiency Virus infection in parturients,” Journal of the American Medical Association, 258 (1987), pp. 2701-2703.
> Lane, R. J., et al. “Myopathy in HIV Infections: The Role of Zidovudine and the Significance of Tubuloreticular Inclusions,” Neuropathy and Applied Neurobiology, 19 (1993), pp. 406-413.
> Lang, D. J., et al., “Seroepidemiological studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type-I infections in selected recipient populations,” Journal of Acquired Immune Deficiency Syndrome, 2 (1989), pp. 540-549.
> Lang, S., “Questions of Scientific Responsibility: The Baltimore Case,” Ethics and Behavior, 3 (1993), pp. 3-72.
> Lang, S., “HIV and AIDS: Questions of scientific and journalistic responsibility,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Lang, S., 'To fund or not to fund, that is the question: propsed experiments on the drug-AIDS hypothesis,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Lang, S., “The Case of HIV and AIDS,” from Challenges, Springer-Verlag, 1998.
> Lang, S., “The Gallo Case,” from Challenges, Springer-Verlag, 1998.
> Lang, W., et al., “Clinical, Immunologic, and Serologic Findings in Men at Risk for Acquired Immunodeficiency Syndrome,” Journal of the American Medical Association, 257 (1987), pp. 326-330.
> Lang, W., et al., “Patterns of T Lymphocyte Changes with Human Immunodeficiency Virus Infection: From Seroconversion to the Development of AIDS,” Journal of Acquired Immune Deficiency Syndrome, 2 (1989), pp. 63-69.
> Lang, W, et al., “Population-based estimates of zidovudine and aerosol pentamidine use in San Francisco,” Journal of Acquired Immune Deficiency Syndrome, 4 (1991), pp. 713-716.
> Lange, W. R., et al., “Nitrite inhalants: contemporary patterns of abuse,” in Health Hazards of Nitrite Inhalants, H.W. Haverkos and J.A. Dougherty (Editors), NIDA Research Monograph 83, U.S. Department of Health and Human Services, Washington, D.C., 1988.
> Langhof, E., et al., “Most CD+ T-cells from Human Immunodeficiency Virus-I Infected Patients Can Undergo Prolonged Clonal Expansion,” Journal of Clinical Investigation, 84 (1989), pp. 1637-1643.
> Larrat, P. E. and S. Zierler, “Entangled Epidemics: Cocaine Use and HIV Disease,” Journal of Psychoactive Drugs, 25 (1993), pp. 207-221.
> Laurence, J., et al., New England Journal of Medicine, 311 (1984), pp. 1269-1273.
> Laurence, J., et al., “Acquired Immunodeficiency Without Evidence of Infection with Human Immunodeficiency Virus Types I and II,” Lancet, 340 (1992), pp. 273-274.
> Laurent-Crawford, A. G., et al., “The cytopathic effect of HIV is associated with apoptosis,” Virology, 185 (1991), pp. 829-839.
> Lauritsen, J., “CDC's tables obscure AIDS-drug connection,” Philadelphia Gay News, February 14, 1985.
> Lauritsen, J., “Poppers and AIDS: The scientific overview,” New York Native, December 1985.
> Lauritsen, J., “The AIDS-drug connection,” New York Native, August 1985.
> Lauritsen, J., “Koch's postulates revisited: Another look at the ‘AIDS virus’ fiasco,” New York Native, October 1986.
> Lauritsen, J., “Caveat emptor: The report of the National Academy of Sciences on AIDS is filled with misinformation,” New York Native, March 1987.
> Lauritsen, J., “First things first: Some thoughts on the ‘AIDS virus’ and AZT,” New York Native, June 1987.
> Lauritsen, J., “Saying no to HIV,” New York Native, July 1987.
> Lauritsen, J., “AZT On Trial,” New York Native, October 1987.
> Lauritsen, J., “AZT update,” New York Native, December 1987.
> Lauritsen, J., “The HIV debate,” New York Native, February 1988.
> Lauritsen, J., “AZT: Iatrogenic genocide,” New York Native, March 1988.
> Lauritsen, J., “AZT disinformation,” New York Native, June 1988.
> Lauritsen, J., “Latex lunacy,” New York Native, July 1988.
> Lauritsen, J., “The epidemiology of fear,” New York Native, August 1988.
> Lauritsen, J., “Incompetence as usual,” New York Native, September 1988.
> Lauritsen, J., “More sloppiness from the NYC health department,” New York Native, September 1988.
> Lauritsen, J., “Epidemiology in graphics,” New York Native, October 1988.
> Lauritsen, J., “AIDS incidence dropping,” New York Native, October 1988.
> Lauritsen, J., “AIDS words from the front: The media report,” Spin, October 1988.
> Lauritsen, J., “The AZT front: Part one,” New York Native, January 1989.
> Lauritsen, J., “The AZT front: Part two,” New York Native, January 1989.
> Lauritsen, J., “Poppers: The end of an era,” New York Native, March 1989.
> Lauritsen, J., “Poppers outlawed in the U.S.,” Capital Gay (London), March 31, 1989.
> Lauritsen, J., “Confusion in the HIV ranks,” New York Native, June 1989.
> Lauritsen, J., “Science by press release,” New York Native, August 1989.
> Lauritsen, J., “The case against AZT,” PWA Coalition Newsline, September 1989.
> Lauritsen, J., “AZT and cancer,” New York Native, October 1989.
> Lauritsen, J., “AZT causes cancer: Burroughs Wellcome issues advisory,” New York Native, December 1989.
> Lauritsen, J., “U.S. cuts AZT dose in half: Burroughs Wellcome considering recommending AZT for symptomless HIV-infected people,” New York Native. January 1990.
> Lauritsen, J., “More science by press conference: FDA committee recommends AZT for healthy people,” New York Native, February 1990.
> Lauritsen, J., “A 'state of the art' AZT conference: VA doctor finds no benefit from AZT treatment,” New York Native, March 1990.
> Lauritsen, J., “Debate over AIDS incidence,” New York Native, April 1990.
> Lauritsen, J., “AZT watch: New research does not prove efficacy,” New York Native, April 1990.
> Lauritsen, J., “They left their HIV in San Francisco,” New York Native, July 1990.
> Lauritsen, J., “Inside the AIDS information bulletin board,” New York Native, July 1990.
> Lauritsen, J., “Lesbian and gay health providers: Friends or foes?,” New York Native, August 1990.
> Lauritsen, J., “The great AIDS hoax,” Random Lengths, November 1990.
> Lauritsen, J., AIDS epidemiology and risk reduction guidelines, Asklepios Press, New York, 1990.
> Lauritsen, J., Poison by Prescription - The AZT Story, Asklepsios Press, New York, 1990.
> Lauritsen, J., “HIV VooDoo From Burroughs-Wellcome,” New York Native, January 1991.
> Lauritsen, J., “FDA Has Second Thoughts On AZT,” New York Native, March 4, 1991.
> Lauritsen, J., “The AIDS War: Lies and censorship in AIDS coverage,” New York Native, August 12, 1991.
> Lauritsen, J., “Kramer vs. Kramer's children,” New York Native, October 1991.
> Lauritsen, J., “Something rotten in the British AIDS establishment,” New York Native, February 1992.
> Lauritsen, J., “FDA Documents Show Fraud in AZT Trials,” New York Native, March 30, 1992.
> Lauritsen, J., “AIDS criticism in Europe,” New York Native, June 1992.
> Lauritsen, J., “Research fraud,” Lancet, 8, August 1992.
> Lauritsen, J., “Petrushka was poisoned,” New York Native, February 1993
> Lauritsen, J., “Surveying Ascher and Schechter,” Rethinking AIDS, May 1993.
> Lauritsen, J., “Dissent at the Berlin AIDS conference,” Rethinking AIDS, July 1993.
> Lauritsen, J., “Looking back on Berlin,” HEAL Quarterly (New York), Fall/Winter 1993.
> Lauritsen, J., AIDS War: Propaganda, Profiteering and Genocide from the Medical-Industrial Complex, Asklepsios Press, New York, 1993.
> Lauritsen, J., “NIDA meeting discusses poppers-KS connection,” San Francisco Sentinel, June 1994.
> Lauritsen, J., “NIDA meeting calls for research into the poppers Kaposi's sarcoma connection,” New York Native, June 1994.
> Lauritsen, J., “HIV symposium at AAAS conference: Truth is bustin' out all over,” New York Native, July 1994.
> Lauritsen, J., “NIH Reconsiders Nitrite’s Link to AIDS,” Bio/Technology, 12 (1994), pp. 762-763.
> Lauritsen, J., “The Risk-AIDS Hypothesis,” Alternative AIDS Symposium, Buenos Aires, April 1995.
> Lauritsen, J., “HIV symposium at AAAS conference,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Lauritsen, J., “NIDA meeting calls for research into the poppers-Kaposi's sarcoma connection,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Lauritsen, J., 'The incidence quagmire,” AIDS: Virus or Drug Induced?, P. Duesberg (Editor), Kluwer Academics Publishers, Netherlands, 1996.
> Lauritsen, J. and H. Wilson, Death Rush, Poppers and AIDS, Pagan Press, New York, 1986.
> Lauritsen, J. and I. Young (Editors), The AIDS Cult: Essays on the gay health crisis, Pagan Press, New York, 1997.
> Lawrence, D. N., et al., “HIV Transmission from Hemophiliac Men to their Heterosexual Partners,” Heterosexual Transmission of AIDS, N.J. Alexander, H.L. Gabelnick & J.M. Spieler (Editors), Wiley-Liss, New York, 1990, pp. 35-53.
> Layon, J., et al., “Altered T-lymphocyte Subsets in Hospitalized Intravenous Drug Abusers,” Archives of Internal Medicine, 144 (1984), pp. 1376-1380.
> Learmont, J., et al., “Long-term Symptomless HIV-I Infection in Recipients of Blood Products from a Single Donor,” Lancet, 340 (1992), pp. 863-867.
> Lee, C. A., et al., “Progression of HIV disease in a haemophiliac cohort followed for 11 years and the effect of treatment,” British Medical Journal, 303 (1991), pp. 1093-1096.
> Leland, J., “The End of AIDS?,” Newsweek, December 2, 1996, pp. 64-73.
> Lemaitre, M., et al., “Protective Activity of Tetracycline Analogs Against the Cytopathic Effect of the Human Immunodeficiency Viruses in CEM Cells,” Research in Virology, 141 (1990), pp. 5-16.
> Lemp, G. E., et al., “Projections of AIDS Morbidity and Mortality in San Francisco,” Journal of the American Medical Association, 263 (1990), pp. 1497-1501.
> Lenderking, W. R., et al., “Evaluation of the Quality of Life Associated with Zidovudine Treatment in Asymptomatic Human Immunodeficiency Virus Infection,” New England Journal of Medicine, 330 (1994), pp. 738-743.
> Lepage, P., et al., “Perinatal transmission of HIV-I: lack of impact of maternal HIV infection on characteristics of livebirths and on neonatal mortality in Kigali, Rwanda,” AIDS, 5 (1991), pp. 295-300.
> Lerner, W. D., “Cocaine Abuse and Acquired Immunodeficiency Syndrome: Tale of Two Epidemics,” American Journal of Medicine, 87 (1989), pp. 661-663.
> Lesbian and Gay Substance Abuse Planning Group, Gay Men, Lesbians, and Their Alcohol and Other Drug Use: A Review of the Literature, San Francisco Department of Public Health, San Francisco, CA, 1991.
> Levy, J., “Mysteries of HIV: Challenges for Therapy and Prevention,” Nature (London), 333 (198), pp. 519-522.
> Lewis, A., “Down the tabloid slop,” New York Times, July 4, 1994.
> Lewis-Thorton, R., “Facing AIDS,” Essence (New York), December 1994.
> Lifson, A. R., et al., “Kaposi’s Sarcoma in a Cohort of Homosexual and Bisexual Men: Epidemiology and Analysis for Cofactors,” American Journal of Epidemiology, 131 (1990), pp. 221-231.
> Liversidge, A., “AIDS: Words from the Front,” Spin, 12 (1989).
> Liversidge, A., “Heresy! Modern Galileos,” Omni, 48 (1993).
> Lo, S. C., et al., “Enhancement of HIV-I cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma,” Science, 251 (1991), pp. 1074-1076.
> Louria, D. B., “Infectious Complications of Nonalcoholic Drug Abuse,” Annual Review of Medicine, 25 (1974), pp. 219-231.
> Lowdell, C. P., et al., “Long term survival of male homosexual patients with Kaposi’s sarcoma,” Journal of the Royal Society of Medicine, 82 (1989), pp. 226-227.
> Lu, W. and J. M. Andrieu, “Similar replication capacities of primary Human Immunodeficiency Virus Type I isolates derived from a wide range of clinical sources,” Journal of Virology, 66 (1992), pp. 334-340.
> Luca-Moretti, M., “Specific behavioral factors among intravenous drug users have been shown to influence HIV seroconversion,” Journal Intern. Med. Health Association, 1 (1992), pp. 1-9.
> Ludlam, C. A., et al., Human T-lymphocyte virus type III (HTLV-III) inaction in seronegative hemophiliacs after transfusion of factor VIII,” Lancet, ii (1985), pp. 233-236.
> Ludlam, C. A., “AIDS: the alternative view,” Lancet, 339 (1992), pp. 1547-1548.
> Lui, K., et al., “A model-based estimate of the mean incubation period for AIDS in homosexual men,” Science, 240 (1988), pp. 1333-1335.
> Lundgren, I. D., et al., “Comparison of long-term prognosis of patients with AIDS treated and not treated with Zidovudine,” Journal of the American Medical Association, 271 (1994), pp. 1088-1092.
> Lusso, P., et al., “Induction of CD4 and susceptibility to HIV-I infection in human CD8+ T lymphocytes by human herpes virus 6,” Nature (London), 349 (1991), pp. 533-535.

M

> Macilwain, C., “AAAS criticized over AIDS skeptics’ meeting,” Nature (London), 369 (1994), p. 265.
> Maddox, J., Nature (London), 333 (1988), p. 11.
> Maddox, J., “AIDS research turned upside down,” Nature (London), 353 (1991), p. 297.
> Maddox, J., “Basketball, AIDS and education,” Nature (London), 354 (1991), p. 103.
> Maddox, J., “Rage and Confusion Hide Role of HIV,” Nature, 357 (1992), pp. 188-189.
> Masddoc, J., “Humbling of world’s AIDS researchers,” Nature (London), 358 (1992), p. 367.
> Maddox, J., “Where the AIDS Virus Hides Away,” Nature, 362 (1993), p. 287.
> Maddox, J., “Has Duesberg A Right of Reply?,” Nature, 363 (1993), p. 109.
> Maddox, J., “Duesberg and the New View of AIDS,” Nature (London), 373 (1995), p. 189.
> Maddox, J. “More Conviction on HIV and AIDS,” Nature (London), 377 (1995), p. 1
> Madhok, R., et al., “Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus,” British Medical Journal, 293 (1986), pp. 978-980.
> Maggiore, C., What if everything you thought you knew about AIDS was wrong?, American Foundation for AIDS Alternatives, 2000.
> Mahir, W. S., et al., “Functional studies of cell-mediated immunity in haemophilia and other bleeding disorders,” British Journal of Haemotology, 69 (1988), pp. 367-370.
> Maikel, R. P., “The fate and toxicity of butyl nitrites,” in Health Hazards of Nitrite Inhalants, H.W. Haverkos and J.A. Dougherty (Editors), NIDA Research Monograph 83, U.S. Department of Health and Human Services, Washington, D.C., 1988.
> Mann, J., et al., “The International Epidemiology of AIDS,” Scientific American, 259 (1988), pp. 82-89.
> Mann, J. and Global AIDS Policy Coalition, AIDS in the World, Harvard International AIDS Center, 1992.
> Mannucci, P. M., et al., “Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-priority of an intermediate purity factor VIII concentrate,” Journal of Thrombosis and Haemostasis, 67 (1992), pp. 310-313.
> Mansuri, M. M., et al., “Comparison of In Vitro Biological Properties and Mouse Toxicities of Three Thymidine Analogs Active Against Human Immunodeficiency Virus,” Antimicrobial Agents in Chemotherapy, 34 (1990), pp. 637-641.
> Marion, S. A., et al., “Evidence That Prior Immune Dysfunction Predisposes to Human Immunodeficiency Virus Infection in Homosexual Men,” Journal of Acquired Immune Deficiency Syndrome, 2 (1989), pp. 178-186.
> Marmor, M. A., et al., “Risk Factors for Kaposi's Sarcoma in Homosexual Men,” Lancet, i (1982), pp. 1083-1087.
> Marquart, K. H., et al., “An 8-year history of Kaposi’s sarcoma in an HIV-negative bisexual man,” AIDS, 5 (1991), pp. 346-348.
> Martin, D. J., et al., “CD4+ Lymphocyte Count in African Patients Co-Infected with HIV and Tuberculosis,” Journal of Acquired Immune Deficiency and Human Retrovirology, 8 (1995), pp. 386-391.
> Marx, J., “Circumcision may protect against the AIDS virus,” Science, 245 (1989), pp. 470-471.
> Mathe, G., “Is the AIDS virus responsible for the disease?,” Biomed. Pharmacother., 46 (1992), pp. 1-2.
> Matheson, D. S., et al., “Humoral immune response in patients with hemophilia,” Clinical Immunology and Immunopathology, 4 (1987), pp. 41-50.
> Mathur-Wagh, U., et al., “Longitudinal Study of Persistent Generalized Lymphadenopathy in Homosexual Men: Relation to Acquired Immunodeficiency Syndrome,” Lancet, i (1984), pp. 1033-1038.
> Mathur-Wagh, U., et al., “Follow-up of 4 ½ years on homosexual men with generalized lymphadenopathy,” New England Journal of Medicine, 313 (1985), pp. 1542-1543.
> Maynard, T., “Factor concentrate is a co-factor,” AIDS News, 8 (1994), p. 1.
> Mazzitelli, T., “AIDS Profits Take Off 'Like Any Other Business',” Gemini News Service, November 20, 1987.
> McCormick, D., “Right of Reply,” Bio/Technology, 11 (1993), p. 955.
> McDonough, R. J., et al., “Alteration of T and Null Lymphocyte Frequencies in the Peripheral Blood of Human Opiate Addicts: In Vivo Evidence of Opiate Receptor Sites on T Lymphocytes,” Journal of Immunology, 125 (1980), pp. 2539-2543.
> McDunn, S. H., et al., “Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies and immune deficiency,” Journal of Clinical Oncology, 9 (1991), pp. 1334-1340.
> McGrady, G. A., et al., “The course of the epidemic of acquired immunodeficiency syndrome in the United States hemophilia population,” American Journal of Epidemiology, 126 (1987), pp. 25-80.
> McKee, M., “Defense puts AIDS virus on trial,” The Recorder, January 17, 1992.
> McKegney, F. P., et al., “A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadonemaintained patients,” AIDS, 4 (1990), pp. 565-569.
> McKenna, J. J., et al., “Unmasking AIDS: Chemical Immunosuppression and Seronegative Syphilis,” Medical Hypotheses, 21 (1986), pp. 421-430.
> McKeown, T., The Role of Medicine: Dream, Mirage, or Nemesis?, Princeton University Press, Princeton, 1979.
> McLeod, G. X. and S. M. Hammer, “Zidovudine: Five Years Later,” Annals of Internal Medicine, 117 (1992), pp. 487-501.
> McMurran, K. and M. Neil, “One Woman’s Brave Battle with AIDS,” People, July 1990.
> McNamee, L. J. and B. F. McNamee, AIDS: The Nation’s First Politically Protected Disease, National Medical Legal Publishing House, California, 1988.
> Meduir, G. U., et al., “Pulmonary Karposi’s Sarcoma in the Acquired Immune Deficiency Syndrome: Clinical, Radiographic, and Pathologic Manifestations,” American Journal of Medicine, 81 (1986), pp. 11-18.
> Menitove, J. E., et al., “T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophized concentrates,” New England Journal of Medicine, 308 (1983), pp. 83-86.
> Merson, M. H., “Slowing the Spread of HIV: Agenda for the 1990’s,” Science, 260 (1993), pp. 1266-1268.
> Mesce, D., “AZT-Tumors,” Associated Press, December 5, 1989.
> Messiah, A., et al., “Risk factors for AIDS among homosexual men in France,” European Journal of Epidemiology, 4 (1988), pp. 68-74.
> Mientjes, G. H. C., et al., “Frequent Injecting Impairs Lymphocyte Reactivity in HIV-Positive and HIV-negative Drug Users,” AIDS, 5 (1991), pp. 35-41.
> Mientjes, G. H. C., et al., “Increasing morbidity without the rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam,” AIDS, 6 (1992), pp. 207-212.
> Mientjes, G. H. C., et al., British Journal of Haematology, 82 (1992), pp. 615-619.
> Mientjes, G. H. C., et al., “Clinical Symptoms Associated With Seroconversion for HIV-I Among Misusers of Intravenous Drugs: Comparison with Homosexual Seroconverters and Infected and Noninfected Intravenous Drug Misusers,” British Medical Journal, 306 (1993), pp. 371-373.
> Mintz, M., “Anatomy of a Tragedy,” New York Newsday, October 3, 1989.
> Miller, J., “AIDS Heresy,” Discover, 66 (June 1988).
> Mills, J. and H. Masur, “AIDS-related infections,” Scientific American, 263 (1990), pp. 5-57.
> Mir, N. and C. Costello, “Ziduvodine and Bone Marrow,” Lancet, ii (1988), pp. 1195-1995.
> Mirken, B., “Everything You Always Wanted to Know About Poppers; The ‘Gay Drug’ Is Still Here Despite a Ban, and So Is the Controversy,” San Francisco Frontiers Newsmagazine, 14 (July 20, 1994), pp. 16-19.
> Mirvish, S. S. and H. W. Haverkos, “Butylnitrite in the induction of Kaposi’s sarcoma in AIDS,” New England Journal of Medicine, 317 (1987), p. 1603.
> Mirvish, S. S., et al., “Indications from animal and chemical experiments of a carcinogenic role for isobutyl nitrite,” in Health Hazards of Nitrite Inhalants, H.W. Haverkos and J.A. Dougherty (Editors), NIDA Research Monograph 83, U.S. Department of Health and Human Services, Washington, D.C., 1988.
> Mirvish, S. S., et al., “Mutagenicity of Iso-butyl Nitrite Vapor in the Ames Test and Some Relevant Chemical Properties, Including the Reaction of Iso-butyl Nitrite with Phosphate,” Environmental and Molecular Mutagenesis, 21 (1993), pp. 247-252.
> Moffat, E. H. and A. L. Bloom, “HTLV-III antibody status and immunological abnormalities in haemophiliac patients,” Lancet, ii (1985), p. 935.
> Mok, J. Q., et al., “Infants Born to Mothers Seropositive for Human Immunodeficiency Virus,” Lancet, i (1987), pp. 1164-1168.
> Montagnier, L., et al., “A new human T-lymphotropic retrovirus: characterization and possible role in lymphadenopathy and acquired immune deficiency syndromes,” in Human T-Cell Leukemia/Lymphoma Virus: the Family of Human T-Lymphotropic Retroviruses: Their Role in Malignancies and Association with AIDS, R.C. Gallo, M.E. Essex and L. Gross (Editors), Cold Spring Harbor Laboratory, New York, 1984, pp. 363-379.
> Montefiori, D. C., et al., “Neutralizing and Infection-enhancing Antibody Responses to Human Immunodeficiency Virus Type I in Long-term Nonprogressors,” Journal of Infectious Diseases, 173 (1996), pp. 60-67.
> Moore, J. D., et al., “HTLV-III Seropositivity In 1971-1972 Parental Drug Abusers - A Case of False Positives or Evidence of Viral Exposure?,” New England Journal of Medicine, 314 (1986), pp. 1387-1388.
> Moore, P. S. and Y. Chang, “Detection of Herpes-like DNA Sequences in Kaposi's Sarcoma in Patients with and Those Without HIV Infection,” New England Journal of Medicine, 332 (1995), pp. 1181-1185.
> Morgan, M., et al., “The Future Course of AIDS in the United States,” Journal of the American Medical Association, 263 (1990), pp. 1539-1540.
> Moss, A. R., “AIDS and Intravenous Drug Use: The Real Heterosexual Epidemic,” British Medical Journal, 294 (1987), pp. 389-390.
> Moss, A. R., et al., “Risk factors for AIDS and HIV seropositivity in homosexual men,” American Journal of Epidemiology, 125 (1987), pp. 1035-1047.
> Moss, A. R., et al., “The Cause of AIDS,” Science, 242 (1988), p. 997.
> Mulder, “A Case of Mistaken Non-Identity,” Nature, 331 (1988), p. 374.
> Mullis, K. B., “A hypothetical disease of the immune system that may bear some relation to the Acquired Immune Deficiency Syndrome,” Genetica, 95 (1995), pp. 195-197.
> Munoz, A., et al., “Prognostic Indicators for Development of AIDS Among Intravenous Drug Users,” Journal of Acquired Immune Deficiency Syndrome, 5 (1992), pp. 694-700.
> Munoz, A., “Disease Progression 15 Percent of HIV-infected Men Will Be Long-term Survivors,” AIDS Weekly, News Report, May 15 and May 29, 1995.
> Munoz, A., et al., “Long-term Survivors with HIV-I Infection: Incubation Period and Longitudinal Patterns of CD4+ Lymphocytes,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8 (1995), pp. 496-505.
> Murray, H. W., et al., “T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome,” Archives of Internal Medicine, 148 (1988), pp. 1613-1616.

N

> Nair, P., et al., “Maternal and Neonatal Characteristics Associated with HIV Infection in Infants of Seropositive Women,” Journal of Acquired Immunodeficiency Syndrome, 6 (1993), pp. 298-302.
> Nakamura, N. et al., “Endogenous retroviral LTR DNA sequences as markers for individual human chromosomes,” Cytogenet. Cell Genet., 57 (1991), pp. 18-22.
> National Commission on AIDS, The Twin Epidemics of Substance Abuse and HIV, July 1991.
> National Institute of Allergy and Infectious Diseases, NIAID Backgrounder: How HIV Causes AIDS, National Institutes of Health, 1994.
> Nelson, J., et al., “Magic Reeling as Worst Nightmare Comes True – He’s Getting Sicker,” National Enquirer, December 10, 1991.
> Newell, G. R., et al., “Volatile Nitrites: Use and Adverse Effects Related to the Current Epidemic of the Acquired Immune Deficiency Syndrome,” American Journal of Medicine, 78 (1985), pp. 811-816.
> Newell, G. R., et al., “Risk Factor Analysis Among Men Referred for Possible Acquired Immune Deficiency Syndrome,” Preventive Medicine, 14 (1985), pp. 81-91.
> Newell, G. R., et al., “Nitrite Inhalants: Historical Perspective,” in Health Hazards of Nitrite Inhalants, H.W. Haverkos and J.A. Dougherty (Editors), NIDA Research Monograph 83, National Institute on Drug Abuse, Maryland, 1988.
> Nicholson, J., “Rebel Scientists: HIV Doesn't Cause AIDS,” New York Post, July 23, 1992.
> Nicolosi, A., et al., “Incidence and Risk Factors of HIV Infection: A Prospective Study of Seronegative Drug Users from Milan and Northern Italy, 1987-1989,” Epidemiology, 1 (1990), pp. 453-459.
> Nieman, R. B., et al., “The Effects of Cigarette Smoking on the Development of AIDS in HIV-I-Seropositive Individuals,” AIDS, 7 (1993), pp. 705-710.
> Novick, D. M., et al., “Influence of sexual preference and chronic hepatitis B virus infection on T lymphocyte subsets, natural killer activity, and suppressor cell activity,” Journal of Hepatology, 3 (1986), pp.363-370.
> Novick, D. M., et al., “Natural Killer Cell Activity and Lymphocyte Subsets in Parenteral Heroine Abusers and Long-term Methadone Maintenance Patients,” The Journal of Pharmacology and Experimental Therapeutics, 250 (1989), pp. 606-610.
> Null, G., “Aids is not a death sentence,” Penthouse, February 1994.
> Null, G., “The big lie about aids,” Penthouse, April1994.
> Null, G., et al., "Death by Medicine," Life Extension Magazine, March 2004.
> Nussbaum, B., Good Intentions: How Big Business, Politics, and Medicine are Corrupting The Fight Against AIDS, Atlantic Monthly Press, 1990.

O

> O’Brien, T. R., et al., “Human immunodeficiency virus type 2 infection in the United States,” Journal of the American Medical Association, 267 (1992), pp. 2775-2779.
> Oddone, E. Z., et al., “Cost-effectiveness analysis of early zidovudine treatment of HIV infected patients,” British Medical Journal, 307 (1993), pp. 1322-1325.
> Office of AIDS Research and Division of Safety, “HIV Safety Notice,” National Institutes of Health, February 23, 1989.
> O’Loughlin, R., “Lawsuit Charges Collusion Between Feds, AZT Maker,” Bay Area Reporter, 5, November, 1987.
> Oppenheimer, G. M., “Causes, cases, and cohorts: The role of epidemiology in the historical construction of AIDS,” AIDS: The Making of a Chronic Disease, E. Fee and D.M. Fox (Editors), University of California Press, Berkeley, 1992, pp. 49-83.
> Osterloh, J. and K. Olson, “Toxicities of akylnitrites,” Annals of Internal Medicine, 104 (1986), p. 727.
> Ostrom, N., “New York Times Inserts Propaganda in Letter,” New York Native, November 8, 1993.
> Ostrom, N., “Shalala Defends HIV Against Congressman’s Challenge,” New York Native, July 31, 1995.
> Ostrom, N., “Early Intervention: An Idea Whose Time Has Gone?,” New York Native, August 28, 1995.
> Ostrom, N., “Nightmare on AZT Street,” New York Native, September 4, 1995.
> Ostrow, D. G., et al., “Recreational Drug Use and Sexual Behavior Change in a Cohort of Homosexual Men,” AIDS, 4 (1990), pp. 759-765.
> Ostrow, D. G., et al., “Recreational Drugs and Sexual Behavior in the Chicago MACS/CCS Cohort of Homosexually Active Men,” Journal of Substance Abuse, 5 (1993), pp. 311-325.
> Ostrow, D. G., “Substance Abuse and HIV Infection,” Psychiatric Manifestations of HIV Disease, 17 (1994), pp. 69-89.
> Ostrow, D. G., et al., “A Case-Control Study of Human Immunodeficiency Virus Type I Seroconversion and Risk-Related Behaviors in the Chicago MACS/CCS Cohort, 1984-1992,” American Journal of Epidemiology, 142 (1995), pp. 875-883.
> Ou, C. Y., et al., “Molecular epidemiology of HIV transmission in a dental practice,” Science, 256 (1992), pp. 1165-1171.

P

> Palca, J., “A reliable animal model for AIDS,” Science, 248 (1990), p. 1078.
> Palca, J., “The sobering geography of AIDS,” Science, 252 (1991), pp. 372-373.
> Palca, J., “Hints emerge from the Gallo probe,” Science, 253 (1991), pp. 728-731.
> Palca, J., “The Case of the Florida Dentist,” Science, 255 (1992), pp. 392-394.
> Palca, J., “No Trial to Come in Florida Dentist Case,” Science, 255 (1992), p. 787.
> Palca, J., “CDC closes the case of the Florida dentist,” Science, 256 (1992), pp. 1130-1131.
> Pallangyo, K. J., et al., “Clinical case definition of AIDS in African adults,” Lancet, ii (1987), p. 972.
> Pantello, G., et al., “HIV Infection is Active and Progressive in Lymphoid Tissue During the Clinically Latent Stage of Disease,” Nature (London), 362 (1993), pp. 355-358.
> Pantello, G., et al., “Studies in Subjects with Long-term Nonprogressive Human Immunodeficiency Virus Infection,” New England Journal of Medicine, 332 (1995), pp. 209-216.
> Papdopulos-Eleopulos, E., “Reappraisal of AIDS – Is the oxidation induced by the risk factors the primary cause?,” Medical Hypotheses, 25 (1988), pp. 151-162.
> Papdopulos-Eleopulos, E., et al., “Kaposi's Sarcoma and HIV,” Medical Hypotheses, 39 (1992), pp. 22-29
> Papdopulos-Eleopulos, E., et al., “Is a Positive Western Blot Proof of HIV Infection?,” Biotechnology, 11 (1993), pp. 696-707.
> Papdopulos-Eleopulos, E., et al., “Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship,” Genetica (1994).
> Papdopulos-Eleopulos, E., et al., “A critical analysis of the HIV-T4-cell-AIDS hypothesis,” Genetica, 95 (1995), pp.5-24.
> Parker, W. B. and Y. C. Cheng, “Mitochondrial Toxicity of Antiviral Nucleoside Analogs,” Journal of National Institutes of Health Research, 6 (1994), pp. 57-61.
> Peterman, T. A., et al., “Risk of Human Immunodeficiency Virus transmission from heterosexual adults with transfusion-associated infections,” Journal of the American Medical Association, 259 (1988), pp. 55-58.
> Peters, B. S., et al., “Changing disease patterns in patients with AIDS in a referral center in the United Kingdom: the changing face of AIDS,” British Medical Journal, 302 (1991), pp. 203-207.
> Phair, J., et al., “ Acquired Immune Deficiency Syndrome Occurring Within Five Years of Infection With Human Immunodeficiency Virus Type-I: The Multicenter AIDS Cohort Study,” Journal of Acquired Immune Deficiency Syndrome, 5 (1992), pp. 490-496.
> Phillips, A. N., et al., “Viral burden in HIV infection,” Nature (London), 367 (1994), p. 124.
> Phillips, A. N., et al., “Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV infection,” British Medical Journal, 309 (1994), pp. 309-313.
> Piatek, M. et al., “High Levels of HIV-I in Plasma During All Stages of Infection Determined by Competitive PCR,” Science, 259 (1993), pp. 1749-1754.
> Pifer, L.L., “Pneumocystis carinii: a misunderstood opportunist,” European Journal of Clinical Microbiology, 3 (1984), pp. 169-173.
> Pillai, R., et al., “AIDS, Drug Abuse and the Immune System: A Complex Immunotoxilogical Network,” Archives of Toxicology, 65 (1991), pp. 609-617.
> Pillari, G. and J. Narus, “Physical Effects of Heroine Addiction,” American Journal of Nursing, 73 (1973), pp. 2105-2109.
> Piot, P., et al., “AIDS: an international perspective,” Science, 243 (1988), pp. 573-579.
> Pitchenik, A. E., et al., “Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related diseases among 71 consecutive patients in whom tuberculosis was diagnosed: a retrospective study,” American Review of Respiratory Diseases, 135 (1987), pp. 875-879.
> Pitchenik, A. E., et al., “Outbreaks of drug-resistant tuberculosis at AIDS center,” Lancet, 336 (1990), pp. 440-441..
> Pizzo, P. A., et al., “Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV Infection,” New England Journal of Medicine, October 6, 1988.
> Pluda, J. M., et al., “Development of Non-Hodgkin Lymphoma in a Cohort of Patients with Severe Human Immunodeficiency Virus (HIV) Infection on Long-term Antiretroviral Therapy,” Annals of Internal Medicine, 113 (1990), pp. 276-282.
> Pollack, S., et al., “Impaired immune function in hemophilia patients treated exclusively with cryoprecipitate: relation to duration of treatment,” American Journal of Hematology, 20 (1985), pp. 1-6.
> Poznansky, M. C., et al., “HIV Positive Patients First Presenting with an AIDS Defining Illness: Characteristics and Survival,” British Medical Journal, 311 (1995), pp. 156-158.
> Prince, H., “The significance of T lymphocytes in transfusion medicine,” Transfusion Medicine Reviews, 16 (1992), pp. 32-43.
> Project Inform, Is HIV the Cause of AIDS?, Project Discussion Paper #5, San Francisco, May 27, 1992.
> Puschel, K. and F. Mohsenian, “HIV-I-Prevalence Among Drug Deaths in Germany,” in Drug Addiction and AIDS, N. Loimer, R. Schmid, and A. Springer (Editors), Springer-Verlag, New York, 1991.
Q

> Quinn, T. C., et al., “AIDS in Africa: an epidemiological paradigm,” Science, 234 (1986), pp. 955-963.
> Quinn, T. C., et al., “Serologic and immunologic studies in patients with AIDS in North America and Africa: the potential role of infectious agents as cofactors in Human Immunodeficiency Virus infection,” Journal of the American Medical Association, 257 (1987), pp. 2617-2621.

R

> Rapoport, R., “Dissident Scientist’s AIDS Theory Angers Colleagues,” Oakland Tribune, January 31, 1988.
> Rapoport, R., “AIDS: The Unanswered Questions,” Oakland Tribune, May 21, 1989.
> Rappaport, J., AIDS Inc.; Scandal of the century, Human Energy Press, San Bruno, CA, 1988.
> Rasnick, D., “Inhibitors of HIV Protease Useless Against AIDS Because HIV Doesn't Cause AIDS,” Reappraising AIDS, 4 (1996), pp. 1-4.
> Rayment, T. and N. Hodgkinson, “AIDS Hopes Dashed By Terrible Truth On AZT,” The Sunday Times (London), April 10, 1994.
> Raymond, C. A., “Combating a Deadly Combination: Intravenous Drug Abuse, Acquired Immunodeficiency Syndrome,” New England Journal of Medicine, 259 (1988), pp. 329-332.
> Reger, P., “AIDS Prognosis,” Associated Press dispatch, June 3, 1988.
> Regush, N., “AIDS Risk Limited, Studies Suggest,” Montreal Gazette, August 15, 1987.
> Reitz, M.S. and H. Z. Streicher, “Gallo's Virus Sequence,” Nature, 351 (1991), p. 358.
> Rey, S., “The Good News Is, the Bad News Is the Same,” Spy, February 1993, p. 19.
> Rezza, G. et al., “Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males,” European Journal of Epidemiology, 6 (1990), pp. 99-101.
> Richman, D. D., et al., “The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-related Complex,” New England Journal of Medicine, 317 (1987), pp. 192-197.
> Rogers, M. F., et al., “Use of the Polymerase Chain Reaction for Early Detection of the Proviral Sequences of Human Immunodeficiency Virus in Infants Born to Seropositive Mothers,” New England Journal of Medicine, 320 (1989), pp. 1649-1654.
> Rom, M., “Health-Care Workers and HIV: Policy Choice in a Federal System,” Publius, Summer 1993, pp. 135-153.
> Root-Bernstein, R. S., “Do We Know the Cause(s) of AIDS?,” Perspectives in Biology and Medicine, 33 (1990), pp. 480-500.
> Root-Bernstein, R. S., “Multiple-antigen-mediated autoimmunity (MAMA) in AIDS: a possible model for postinfectious autoimmune complications,” Research in Immunology, 141 (1990), pp. 321-339.
> Root-Bernstein, R. S., “Non-HIV immunosuppressive factors in AIDS: a multifactorial, synergistic theory of AIDS etiology,” Research in Immunology, 141 (1990), pp. 815-838.
> Root-Bernstein, R. S., Rethinking AIDS; The tragic cost of premature consensus, Free Press, 1993.
> Root-Bernstein, R. S., “The Duesberg Phenomenon: What Does It Mean?,” Science, 267 (1995), p. 159.
> Root-Bernstein, R. S., “Five Myths About AIDS that Have Misdirected Research and Treatment,” Genetica, 95 (1995), pp. 111-132.
> Root-Bernstein, R. S. and S. Hobbs de Witt, “'Semen alloantigens and lymphocytotoxic antibodies in AIDS and ICL,” Genetica, 95 (1995), pp. 133-156.
> Rosenberg, M. J., and J. M. Weiner, “Prostitutes and AIDS: a health department priority?,” American Journal of Public Health, 78 (1988), pp. 418-423.
> Rotello, G., “A Deal with the Devil,” The Advocate, October 1996.
> Rubenstein, E., “The Untold Story of HUT78,” Science, 248 (1990), pp. 1499-1507.

S

> Saah, A. J., et al., “Predictors for Failure of Pneumocystis Carinii Pneumonia Prophylaxis,” Journal of the American Medical Association, 273 (1995), pp. 1197-1202.
> Sadownick, D., “Kneeling at the Crystal Cathedral,” Genre, December/January 1994, pp. 40-45, 86-90.
> Safai, B. et al., “Kaposi’s sarcoma among HIV-negative High Risk Population,” VII International Conference on AIDS, Florence, Italy, 1991.
> Salahuddin, S. K., et al., “Angiogenic Properties of Kaposi's Sarcoma-derived Cells After Long-term Culture In Vitro,” Science, 242 (1988), pp. 430-433.
> Samter, M., et al., Immunological Diseases, I, Little, Brown and Company, Boston, 1988.
> Sande, M. A., “Transmissions of AIDS: the case against causal contagion,” New England Journal of Medicine, 314 (1986), pp. 380-382.
> Sapira, J. D., “The Narcotic Addict as a Medical Patient,” American Journal of Medicine, 45 (1968), pp. 555-588.
> Savitz, E. J., “No magic cure, the war on AIDS produces few gains except on Wall Street,” Barron’s, December 16, 1991.
> Savona, S., et al., “Thrombocytopenic Purpura in Narcotics Addicts,” Internal Medicine, 102 (1985), pp. 737-741.
> Schechter, M. T., et al., “HIV-I and the Aetiology of AIDS,” Lancet, 341 (1993), pp. 957-958.
> Schechter, M. T., et al., “ Aetiology of AIDS,” Lancet, 341 (1993), pp. 1222-1223.
> Scheper-Hughes, N. and R. Herrick, “Ethical tangles: Cuba’s highly controversial AIDS and HIV program raises thorny ethical issues,” New Internationalist (UK), May, 1992.
> Schick, R., “The Crazy Case Against AZT,” PWAC Coalition Newsline, November 1989.
> Schmitz, T., “A Personal Experience,” an Open Letter, December 8, 1993.
> Schnittman, S. M., et al., “The Reservoir for HIV-I in Human Peripheral Blood is a T Cell that Maintains Expression of CD4,” Science, 245 (1989), pp. 305-308.
> Schoch, R, “Dad, I’m HIV positive,” Newsweek, August 17, 1992.
> Schulman, S., “Effects of factor VIII concentrates on the immune system in hemophiliac patients,” Annals of Hematology, 63 (1991), pp. 145-151.
> Schupach, J., “First isolation of HTLV-III,” Nature (London), 321 (1986), pp. 119-120.
> Schuster, C. R., “Forward,” in Cocaine: Pharmacology, Effects and Treatment of Abuse, J. Grabowski, Editor, National Institute on Drug Abuse, Washington, D.C., 1984, pp. vii-vii.
> Schwartlaender, B., et al., AIDS/HIV 1991, AZ Hefte, 1992.
> Schwartz, R. H., “Deliberate inhalation of isobutyl nitrite during adolescence: a descriptive study,” in Health Hazards of Nitrite Inhalants, H.W. Haverkos and J.A. Dougherty (Editors), NIDA Research Monograph 83, U.S. Department of Health and Human Services, Washington, D.C., 1988.
> Schwarz, H. P., et al., “High-purity factor concentrates in prevention of AIDS,” Lancet, 343 (1994), pp. 478-479.
> Schwitzer, R. H., “The magical medical media tour,” Journal of the American Medical Association, 267 (1992), pp. 1969-1971.
> Scolaro, M., et al., “Potential Molecular Competition for HIV,” Lancet, 337 (1991), pp. 731-732.
> Seage, G. R., et al., “The relation between nitrite inhalants, unprotected receptive anal intercourse, and the risk of Human Immunodeficiency Virus infection,” Journal of American Epidemiology, 135 (1992), pp. 1-11.
> Seligmann, M., et al., “AIDS - An Immunologic Reevaluation,” New England Journal of Medicine, 311 (1984), pp. 1286-1292.
> Seligmann, M., et al., “Concorde: MRC/ANRS Randomized Double-blind Controlled Trial of Immediate and Deferred Zidovudine in Symptom-free HIV Infection,” Lancet, 33 (1994), pp. 871-881.
> Selik, R. M., et al., “Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends,” AIDS, 1 (1987), pp. 175-182.
> Selik, R. M., et al., “Impact of the 1987 Revision of the Case Definition of Acquired Immune Deficiency Syndrome in the United States,” Journal of Acquired Immune Deficiency Syndrome, 3 (1990), pp. 73-82.
> Selwyn, P. A., et al., “Increased Risk of Bacterial Pneumonia in HIV-Infected Intravenous Drug Users without HIV,” AIDS, 2 (1988), pp. 267-272.
> Selwyn, P. A., et al., “Impact of the AIDS Epidemic on Morbidity and Mortality Among Intravenous Drug Users in a New York City Methadone Maintenance Program,” American Journal of Public Health, 79 (1989), pp.1358-1362.
> Semple, M., et al., “Direct measurement of viraemia in patients infected with HIV-I and its relationship to disease progression and zidovudine therapy,” Journal of Medical Virology, 35 (1991), pp. 38-45.
> Seremetis, S. V., et al., “Three-year randomized study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status,” Lancet, 342 (1993), pp. 700-703.
> Shafer, R. W., et al., AIDS, 5 (1991), pp. 399-405.
> Shannon, E., et al., “A losing battle,” Time, December 3, 1990.
> Sharp, R. A., et al., “Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV),” Journal of Clinical Pathology, 40 (1987), pp. 849-852.
> Shaw, G. M., et al., “Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome,” Science, 226 (1984), pp. 1165-1171.
> Shenton, J., “HIV, AIDS, and zidovudine,” Lancet, 339 (1992), p. 806.
> Shenton, J., Positively False: Exposing the Myths Around HIV and AIDS, I.B.Tauris, 1998.
> Sheppard, H. W., et al., “Viral burden and HIV disease,” Nature (London), 364 (1993), pp. 291-292.
> Shigematsu, I., et al., “Epidemiological Approach to SMON (Subacute Myelo-Optico-Neuropathy),” Japanese Journal of Medicine, Science and Biology, 28 (Supplement) (1975), pp. 23-33.
> Shilts, R., And the Band Played On, St. Martin’s Press, New York, 1985.
> Siegel, L., “AIDS Fear Manifesting Itself in Irrational Ways,” Daily Recorder, March 23, 1987.
> Sigell, L. T., et al., “Popping and Snorting Volatile Nitrites: A Current Fad for Getting High,” American Journal of Psychiatry, 135 (1978), pp. 1216-1218.
> Simmonds, P., et al., “Human Immunodeficiency Virus-infected Individuals Contain Provirus in Small Numbers of Peripheral Mononuclear Cells and at Low Copy Numbers,” Journal of Virology, 64 (1990), pp. 864-872.
> Sloand, E., et al., “Chemotherapy for Patients With Pulmonary Kaposi’s Sarcoma: Benefit of Filgrastim (G-CSF) in Supporting Dose Administration,” Southern Medical Journal, 86 (1993), pp. 1219-1224.
> Smith, D. G., “Thailand: AIDS crisis looms,” Lancet, 335 (1990), pp. 781-782.
> Smith, D. K., et al., “Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection,” New England Journal of Medicine, 328 (1993), pp. 373-379.
> Smith, G. D. and A. N. Phillips, “Confounding in epidemiological studies: why ‘independent’ effects may not be all they seem,” British Medical Journal, 305 (1992), pp. 757-759.
> Smothers, K., “Pharmacology and Toxicology of AIDS Therapies,” The AIDS Reader, I (1991), pp. 29-35.
> Sonnabend, J. A., “The Etiology of AIDS,” AIDS Research, 1 (1983), pp. 1-12.
> Sonnabend, J. A., “A multifactorial model for the development of AIDS in homosexual men,” Annals of the New York Academy of Sciences, 437 (1983), pp. 177-183.
> Sonnabend, J. A., “Caution on AIDS Viruses,” Nature, 310 (1984), p. 103.
> Sonnabend, J. A., “Review of AZT Multi-center Trial Data Obtained Under the Freedom of Information Act by Project Inform and ACT-UP,” AIDS Forum, January 1988.
> Specter, M., “Panel Rebuts Biologist’s Claims on Cause of AIDS,” Washington Post, April 10, 1988.
> Specter, M., “AIDS Virus Likely Fatal To All Infected,” Washington Post, June 3, 1988.
> Spira, T. J. and B. M. Jones, “Is There Another Agent That Causes Low CD4 Counts and AIDS?,” Journal of Cellular Biochemistry, (Supplement) 16E (1992), p. 56.
> Spira, T. J., et al., New England Journal of Medicine, 328 (1993), pp. 386-392.
> Staff and Brubaker, The AIDS Epidemic, Warner Books, New York, 1985.
> Spornraft, P. et al., “T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi’s sarcoma in AIDS,” British Journal of Dermatology, 119 (1988), pp. 1-9.
> Steinbrook, R., “Scientists Infect Monkeys with Human AIDS Virus,” Los Angeles Times, June 12, 1992.
> Stehr-Green, J. K., et al., “Hemophilia-associated AIDS in the United States, 1981 to September 1987,” American Journal of Public Health, 78 (1988), pp. 439-442.
> Stehr-Green, J. K., et al., “Geographic variability of hemophilia-associated AIDS in the United States: effect of population characteristics,” American Journal of Hematology, 32 (1989), pp. 178-183.
> Steinbrook, R., “Scientists infect monkeys with human AIDS virus,” Los Angeles Times, June 12, 1992.
> Stewart, G. T., “Uncertainties about AIDS and HIV,” Lancet, i (1989), p. 1325.
> Stewart, G. T., et al., “AIDS – A Different View,” press release at the International Symposium, Amsterdam, May 6, 1992.
> Stewart, G. T., “The epidemiology and transmission of AIDS: a hypothesis linking behavioural and biological determinants to time, person and place,” Genetica, 95 (1995), pp. 173-193.
> St. Louis, M. E., et al., “Human immunodeficiency virus infection in disadvantaged adolescents,” Journal of the American Medical Association, 266 (1991), pp. 2387-2391.
> Stolberg, S., “AIDS Tally to Increase Due to New Definition,” Los Angeles Times, December 31, 1992.
> Stoneburner, R. L., et al., “A Large Spectrum of Severe HIV-I-related Disease in Intravenous Drug Users in New York City,” Science, 242 (1988), pp. 916-919.
> Sullivan, J. L., et al., “Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesvirus,” Journal of Pediatrics, 108 (1986), pp. 504-510.
> Swanson, C. E., et al., “Factors Influencing Outcome of Treatment with Zidovudine of Patients with AIDS in Australia,” AIDS, 4 (1990), pp. 749-757.
> Swinbanks, D., “AIDS Chief Promises a Shift Towards Basic Research,” Nature (London), 370 (1994), p. 494.

T

> Tanaka, M., “Abrams Cautious on Use of New AIDS Drug,” Synapse, 41 (1996), pp. 1, 5.
> Taelman, H., et al., “Tuberculosis and HIV infection,” British Medical Journal, 302 (1991), p. 1206.
> Tedder, R. S., et al., “HIV, AIDS, and zidovudine,” Lancet, 339 (1992), p. 805.
> Temin, H. M., “Proof in the pudding,” Policy Review, 54 (1990), pp. 71-72.
> Terry, C. E. and E. Pellens, The Opium Problem, Bureau of Social Hygiene of New York, 1928.
> Theuer, C. P., et al., Journal of Infectious Diseases, 5 (1990), pp. 399-405.
> Thomas Jr., C. A., et al., “What Causes AIDS?,” Reason, 26 (1994), pp. 18-23.
> Thomas, D., “Risky Business: Taking Stock of AZT’s Future,” Men’s Style, May/June 1995, pp. 54-56, 102-106.
> Thompson, D. A., “A long battle with AIDS,” Time, July 2, 1990.
> Till, M. and K. B. MacDonnell, “Myopathy with Human Immunodeficiency Virus Type I (HIV-I) Infection: HIV-I or Zidovudine?,” Annals of Internal Medicine, 113 (1990), pp. 492-494.
> Tokars, J. I., et al., “Surveillance of HIV Infection and Zidovudine Use among Health Care Workers after Occupational Exposure to HIV-infected Blood,” Annals of Internal Medicine, 118 (1993), pp. 913-919.
> Toufexis, A., “Innocent Victims,” Time, 19 (1991). pp. 51-60.
> Tracey, M., “Mere smoke of opinion: Aids and the Making of the Public Mind,” Inaugural lecture of the Chair of International Communication, University of Salford, England UK, 1995.
> Treichler, P. A., “The country and the city: dreams of Third World AIDS,” in AIDS: The Making of a Chronic Disease, E. Fee and D.M. Fix (Editors), University of California Press, Berkeley, 1992, pp. 386-412.
> Tsoukas, C., et al., “Association of HTLV-III antibodies and cellular immune status of hemophiliacs,” New England Journal of Medicine, 311 (1984), pp. 1514-151.
> Tuller, D., “Uncertain Life After Certain Death,” San Francisco Chronicle, November 24, 1996.
> Turner, C. F., et al., AIDS, Sexual Behavior and Intravenous Drug Use, National Academy Press, Washington, D.C., 1989.

U

> U.S. Department of Health and Human Services, “Annual Emergency Department Data 1993,” Data from the Drug Abuse Warning Network (DAWN), 1993, pp. 81-110.
> U.S. Department of Health and Human Services, National HIV Serosurveillance Summary, Center for Disease Control, Atlanta, 1990.
> U.S. Department of Health and Human Services, “Annual Medical Examiner Data,” Data from the Drug Abuse Warning Network (DAWN), 1994, pp. 1-82.

V

> Valentine, C. B., et al., “Anonymous Questionnaire to Assess Consumption of Prescribed and Alternative Medication and Patterns of Recreational Drug Use in a HIV Population,” AIDS Weekly, August 10, 1992, p. 18.
> van Griensven, G. J. P., et al., “Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands,” American Journal of Epidemiology, 125 (1987), pp. 1048-1057.
> van Griensven, G. J. P., et al., “Risk Factors for Progression of Human Immunodeficiency Virus (HIV) Infection Among Seroconverted and Seropositive Homosexual Men,” American Journal of Epidemiology, 132 (1990), pp. 203-210.
> van Leeuwen, R., et al., “Failure to Maintain High-Dose Treatment Regimens During Long-term Use of Zidovudine in Patients with Symptomatic Human Immunodeficiency Virus Type I Infection,” Genitourin Medicine, 66 (1990), pp. 418-422.
> van Voorhis, B. J., et al., “Detection of Human Immunodeficiency Virus Type I in Semen from Seropositive Men Using Culture and Polymerase Chain Reaction Deoxyribonucleic Acid Amplification Techniques,” Fertility/Sterility, 55 (1991), pp. 588-594.
> Vanderbroucke, J. P., and V. P. A. M. Pardoel, “An Autopsy of Epidemiologic Methods: The Case of ‘Poppers’ in the Early Epidemic of the Acquired Immunodeficiency Syndrome (AIDS),” Journal of Epidemiology, 129 (1989), pp. 455-457.
> Varchoan, R., et al., “Clinical Pharmacology of 3’-Azido-2’ 3’-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides,” New England Journal of Medicine, September 14, 1989.
> Vermund, S., “Changing Estimates of HIV-I Seroprevalence in the United States,” Journal of National Institutes of Health Research, 3 (1991), pp. 77-81.
> Villinger, F., et al., “Detection of occult simian immunodeficiency virus SIV smm infection in asymtomatic seronegative nonhuman primates and evidence for variation in SIV gag sequence between in vivo- and in vitro-propagated virus,” Journal of Virology, 65 (1991), pp. 1855-1862.
> Volberding, P. A., et al., “Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer than 500 CD4-positive Cells per Cubic Millimeter,” New England Journal of Medicine, 322 (1990), pp. 941-949.
> Volberding, P. A., et al., “A Comparison of Immediate with Deferred Zidovudine Therapy for Asymptomatic HIV-Infected Adults with CD4 Cell Counts of 500 or More per Cubic Millimeter,” New England Journal of Medicine, 333 (1995), pp. 401-407.

W

> Wain-Hobson, S., “Virological Mayhem,” Nature, 373 (1995), p. 102.
> Wainright, M., “Another View on AIDS,” The Scientist, 8 (2004), p. 10.
> Waldholz, M., “Stymied Science: New Discoveries Dim Drug Makers’ Hopes for Quick AIDS Cure,” Wall Street Journal, May 26, 1992.
> Walker, C. M., et al., “CD8+ Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication,” Science, 234 (1986), pp. 1563-1566.
> Walker, R. E., et al., “Anemia and Erythropoiesis in Patients with the Acquired Immunodeficiency Syndrome (AIDS) and Kaposi Sarcoma Treated with Zidovudine,” Annals of Internal Medicine, 108 (1988), pp. 372-376.
> Ward, J. W., et al., “The Natural History of Transfusion-Associated Infection with Human Immunodeficiency Virus,” New England Journal of Medicine, 321 (1989), pp. 947-952.
> Weber, J. N., et al., “Three-year prospective study of HTLV-III/LAV infection in homosexual men,” Lancet, i (1986), pp. 1179-1182.
> Weber, R., et al., “Progression of HIV Infection in Misusers of Injected Drugs Who Stop Injecting or Follow a Programme of Maintenance Treatment with Methadone,” British Medical Journal, 301 (1990), pp. 1362-1365.
> Weisberg, J., “The Accuser: Kimberly Bergalis, AIDS Martyr,” New Republic, October 21, 1991.
> Weisberg, M. S., “AIDS: The New Money-Maker,” Daily News, New York, August 18, 1987.
> Weisberger, J. H., “Chemical Carcinogenesis,” from Toxicology: The Basic Science of Poisons, L.J. Casarett and J. Doull (Editors), McGraw-Hill Professional, 1975.
> Weiss, R., “Provenance of HIV strains,” Nature (London), 349 (1991), p. 374.
> Weiss, R. A., “A Virus in Search of a Disease,” Nature (London), 333 (1988), pp. 497-498.
> Weiss, R. A., “AIDS: defective viruses to blame?,” Nature (London), 338 (1989), p. 458.
> Weiss, R. A., “How does HIV cause AIDS?,” Science, 260 (1993), pp. 1273-1279.
> Weiss, R. and H. Jaffe, “Duesberg, HIV and AIDS,” Nature (London), 345 (1990), pp. 659-660.
> Weiss, S. H., “Links between Cocaine and Retroviral Infection,” Journal of the American Medical Association, 261 (1989), pp. 607-609.
> Weiss, S. H., et al., “Risk of Human Immunodeficiency Virus (HIV-I) infection among laboratory workers,” Science, 239 (1988), pp. 68-71.
> Weiss, S. H., et al., “Idiopathic CD4+ T-lymphocytopenia,” Lancet, 340 (1992), pp. 608-609.
> Wells, J., “We Have to Question the So-Called 'Facts',” Capitol Gay, August 20, 1993, pp. 14-15.
> Weniger, B. G., et al., “The epidemiology of HIV infection and AIDS in Thailand,” AIDS, 5 (Supplement 2) (1991), pp. S71-S85.
> Werth, B., “By AIDS Obsessed,” Gentlemen’s Quarterly, August 1991, pp. 207-208.
> Wesson, D. and D. Smith, “Cocaine: Treatment Perspectives,” in Cocaine Use in America: Epidemiological and Clinical Perspectives, N. Kozel and E. Adams, Eds., MIDA US Department of Health and Human Services, Washington, D.C., 1985.
> Widy-Wirski, R., et al., “Evaluation of the WHO clinical case definition for AIDS in Uganda,” Journal of the American Medical Association, 260 (1988), pp. 3286-3289.
> Williams, A. E., et al., “HTLV-I/II and blood transfusion in the United States,” in Human Retrovirology: HTLV, W.A. Blattner (Editor), Raven Press, New York, 1990, pp. 349-362.
> Williams, A. O., AIDS: An African Perspective, CRC Press, Florida, 1992.
> Williford Pifer, L. L., et al., “Pneumocystis carinii serologic study in pediatric acquired immunodeficiency syndrome,” American Journal of Diseases of Children, 142 (1988), pp. 36-39.
> Willner, R. E., Deadly Deception: The Proof That Sex and HIV Absolutely Do Not Cause AIDS, Peltec Publishing Company, 1994.
> Winkelstein, W., Jr., et al., “Sexual Practices and Risk of Infection by the Human Immunodeficiency Virus: The San Francisco Men's Health Study,” Journal of the American Medical Association, 257 (1987), pp. 321-325.
> Wood, R. W., “The acute toxicity of butyl nitrites,” in Health Hazards of Nitrite Inhalants, H.W. Haverkos and J.A. Dougherty (Editors), NIDA Research Monograph 83, U.S. Department of Health and Human Services, Washington, D.C., 1988.
> World Health Organization, The Current Global Situation of the HIV-AIDS Pandemic, 1995.
> World Health Organization, "Summary of paediatric drug formulations and doses," Guidelines For A Public Health Approach; Scaling Up Antiretroviral Therapy In Resource-Limited Setting, June 2002.
> Wright, K., “Mycoplasmas in the AIDS Spotlight,” Science, 248 (1990), pp. 682-683.
> Wyatt, E. A., “Rushing to Judgment,” Barron's, August 15, 1994, pp. 23-27.

Y

> Yarchoan, R. and S. Broder, “Development of Antiretroviral Therapy for the Acquired Immunodeficiency Syndrome and Related Disorders,” New England Journal of Medicine, 316 (1987), pp. 557-564.
> Yarchoan, R. and S. Broder, “Antiretroviral Therapy for AIDS,” New England Journal of Medicine, 317 (1987), p. 630.
> Yarchoan, R., et al., “Antiretroviral Therapy of Human Immunodeficiency Virus Infection: Current Strategies and Challenges for the Future,” Blood, 78 (1991), pp. 859-884.
> Yogev, R. and E. Conner, “Management of HIV Infection in Infants and Children,” Mosby Year Book, St. Louis, 1992.
> Young, I., “Prescription for Suicide: Gays, AZT and Mind Control,” New York Native, September 12, 1988.
> Young, I., “The Poppers Story: The Rise and Fall and Rise of 'the Gay Drug',” Steam, 2 (4).
> Young, L. S., Pneumocystis Carinii Pneumonia, Marcel Dekker, Inc., New York, 1984.

Z

> Zaretsky, M. D., “AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter?,” Genetica, 95 (1995), pp. 91-101.

Close This Window